About Us
Subscription Plans
Site Features
News
Events
Our Partners
Contact Us
Site Search
>> Advanced Search
Quick Search:
Free Newsletter
Email address:
>> Preview...
In the News
Greg Scott presents industry update during JPMorgan
>>
View video…
>> More News...
Now on Twitter!
Twitter ID:
China
Bio
Free Content
Week in Review
In My Opinion
Free Articles
Education Center
Interfax-BW Releases
SFDA What's New
Subscriber Content
News & Analysis
Featured Companies
Industry Insights
Deals & Financings
Trials & Approvals
Stem Cells
CRO/CMO Services
Gov't & Regulatory
Legal & IP Issues
Stock Watch
Week in Review
Archived Articles
Sitemap
Education Center
Advanced Search
Stem Cells
Beike Biotech Given $1.8 Million Grant for Umbilical Cord Stem Cell Trial
China Cord Blood Pays $20 Million for Stake in Shandong Cord Blood Bank
CRO/CMO Services
Excel and GVK BIO Form China-India CRO Alliance
Excel PharmaStudies Opens Biometrics Center in Taizhou City
Excel PharmaStudies Receives Asia Pacific CRO of the Year Award
ChinaBio® Publishes Proprietary China CRO/CMO List on goBalto
Charles River Labs Looking for 2nd China CRO Site
CRO XenoBiotic to Open Lab in Nanjing
Asymchem Wins Pfizer Award: Opens New Plant;
Eurofins China Central Lab Receives Accreditation
Sundia Acquires Protein Folding Technology
Shanghai ChemPartner and Agios Expand Cancer Drug Collaboration
Express Clearance Cuts Customs Delay to One Day for CRO Sundia MediTech
Shanghai ChemPartner and ELARA Pharma Extend Cancer Drug Work
Charles Rivers’ Shanghai Facility Receives Accreditations
PharmaLegacy's First Year; Accredited by AAALAC
Shanghai ChemPartner Opens European Headquarters
Shanghai ChemPartner Aids Agios’ Cancer Research Breakthrough
Crown Bioscience Forms Cancer Collaboration with Pfizer
AlphaRx Outsources Hepatitis Drug Manufacturing to Venturepharm
Shanghai ChemPartner Places Third in Fast 50 China
Pharmaron Acquires Bridge Labs China
Quintiles' Beijing Lab to Offer Anatomic Pathology Services
CBPF Email Blast - Partners 1
News
Free Articles
7th ChinaBio® Investor Forum Selects Two “Most Promising” Companies
ChinaBio Events Summary
BizCHINA Pharma Industry Videos
Events - OLD
Newsletter Subscription
Previous Polls
Trials & Approvals
Sinobiomed Says Recombinant Batroxobin Effective in Trial
Sinovac Starts Phase II Test of Pandemic Flu Vaccine
China Aoxing Begins Trial for Codeine-based Cold Drug
Immtech Wins Fast-Track for Pafuramidine from SFDA
WEX Publishes Results from Pain Drug Trial
Generex Will Test Cancer Vaccine in China
China Pharma Wins FDA OK for Generic HIV Pill
China Medical Receives Approval for HIFU Device in Korea
Aida Updates Progress on Gene Therapy Cancer Drug
Tongjitang to Seek FDA Approval for TCM Drug
Qiagen Reports Positive Trial for FastHPV Test in China
GNI/Shanghai Genomics to Start China Clinical Trials of Liver Drug
Immtech Conducts Joint US/China Trials for Pneumonia Drug
Second HIV/AIDS Vaccine from China to Start Phase I
AlphaRx Receives SFDA Approval for Topical Arthritis Product
Bird Flu Vaccine from Sinovac Reports Success
Immtech Puts Hold on Clinical Trials of Pafuramidine
Sirnaomics on Track for 2008 Phase I in China
Calypte Oral HIV Test Nears SFDA Approval
China Pharma Wins Approval for Generic Diuretic
AlphaRx to Seek China Approval of Arthritis Drug Indaflex™
Lotus Readies Generic Angina Drug
SurExam Has China Rights to New Ovarian Cancer Test
Pharmaxis Seeks to Run China Trial of Mucus Clearing Drug
Tianyin Wins SFDA Approval for Antibiotic
China Med Granted CE Mark for ECLIA Analyzer
Oculus Announces SFDA Approval of Microcyn
Sinovac Granted SFDA Approval for Avian Flu Vaccine
Frontier Biotechnologies Approved to Test HIV Drug
China Biologic Reports Two SFDA Successes
Takara Bio Reports on Cancer Drug Trial in China
BMP Sunstone Given Go-Ahead for Trials of Enablex®
Simcere Given SFDA Approval for Generic Antibiotic
Sinobiomed to Start Phase II Malaria Vaccine Trial
China Sky One Receives Approval for Two New Products
TCM Effective Against Heart Attacks and Cancer
Hong Kong Researchers Identify Promising Avian Flu Treatment
China Sky One Receives Four More Approvals
Sinovac Starts Phase II Trial of Second Pandemic Flu Vaccine
Chindex Complains about Slow China Medical Device Approvals
Helicon Announces SFDA Approval for ReCell®
China Sky One to Launch Clot Buster Injection
China Sky One Reports 11 Drugs in Clinical Trials
Abraxis Given China Approval for Cancer Drug ABRAXANE
Genesis’s TCM Flu Treatment Approved by SFDA
Bayer Given China Approval for Nexavar
CompuMed Granted SFDA Clearance for Osteoporosis Diagnostic
Tianyin Receives SFDA Approval for Statin
SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial
Roche’s Xeloda Approved in China for Gastric Cancer
FDA Accepts Data from Bridge Labs’ China Facility
Positive Interim Data from Phase IV Test of Simcere’s Endu
China Sky One Has Another 26 Products Awaiting Approval
Tianyin Receives SFDA Approval for TCM Asthma Product
Sinovac Strikes Deal for Healive® in the Ukraine
China Biologic to Start Trial of New Plasma Product
Phytomedics Testing TCM Drug for Rheumatoid Arthritis
3SBio Files for SFDA Approval of High-Dose EPIAO
China Pharma Antibiotic OK’d for Trial
China Sky One Wins SFDA Approval for Two More Products
SFDA Approves China Medical’s HER2 FISH Probe
China AIDS Vaccine Passes Phase I Test
China Sky One Adds TCM Nasal Spray Product
RHEI Begins Final China Trial for Oral Cadidiasis Product
China Sky One Receives Two New SFDA Approvals
Crucell Advances Hepatitis B Vaccine in China
China Aoxing Granted Approval for OTC Pain Drug
China Aoxing Granted Approval for Stroke Product
China Sky One Announces Two More Approvals
Tianyin Pharma Given SFDA OK to Launch Constipation Drug
China Sky One Receives 4 More Product Approvals
Q-Med Granted China Registration for Dermal Filler
Hutchison MediTech Puts Radiation Drug on Hold
LDR Wins China Approval for Artificial Disc
3SBio Now Has Three Drugs Seeking SFDA Approval
China-Biotics Adds Four Probiotic Products
China Medical Approved for Two More FISH Probes
Sinovac Expands into Animal Health
China Pharma Starts Clinical Trial for Hypertension Drug
Biocomposites Synthetic Bone Graft Product is SFDA Approved
China Sky One Granted One Approval, Two Drug Trial OKs
SciGen Receives OK to Sell Recombinant Human Insulin in China
American Oriental to Begin US Clinical Trial of TCM Drug
China Medical’s SPR Diagnostic System Passes Test
China Sky One Given OK for Two New Products
China Medical Tech’s Test for Bladder Cancer Approved
China Aoxing Given SFDA OK for Angina Drug
China Sky One Moves Ahead on Diagnostic Kit for Cardiac Problems
China Sky One Receives Two New Approvals
Neusoft Positron, a China-US JV, Given FDA OK for PET Scanner
China Sky One Receives Another New Product Approval
Solasia Files to Begin China Tests of its Anti-Emetic Patch
NeuroLogical Given SFDA Approval for Portable CT
China Aoxing Completes Trial of Codeine Product
China Pharma Holdings Given OK for Generic Crestor® Trials
Bayer Launches Novel Anti-Clotting Drug in China
TCM May Be Best Treatment for Endometriosis
Uni-Bio to Begin Phase III Trial of Diabetes Drug
Biostar to Introduce Three New TCM Products
Sinovac, Hualan Biological Test Swine Flu Vaccines
SFDA Grants Green Channel Approval to Market Drug without China Trials
Neusoft Medical Granted FDA Approval for High-End CT Scanner
Sinovac Releases Positive Update on A/H1N1 Flu Vaccine Trial
Access Pharma to Start China Trial of US Cancer Drug
Tianyin Granted Two SFDA Approvals
TCM Shown Effective for Rheumatoid Arthritis
Sinovac First Vaccine Maker to Complete Swine Flu Test
Avita Granted China Approval for Wound Healing Kit
TCM OK’d to Begin US Clinical Trials for Hepatitis C
China Pharma Holdings Receives SFDA Approval for Proton Pump Inhibitor
Hengrui Medicine to Put New Diabetes Drug in US Trials
Experts Recommend Approval of Sinovac’s H1N1 Flu Vaccine
Sinovac Approved to Produce H1N1 Vaccine
China Aoxing Submits Codeine Product for Approval
Abbott Granted China Approval for Drug Eluting Stent
China Aoxing Given OK for Trial of Narcotic Drug
Jiangsu Yanshen’s Swine Flu Vaccine Approved by the SFDA
Sinobiopharma Given Certificate for Anti-Coagulant
Celsion Granted SFDA Approval for China Cancer Trial
China Medical Given SFDA Approval for SPR Diagnostic System
China Medicine Registers Vascular Drug in Pakistan
Advanced BioMedical Reports Progress on Orthopedic Screw
Sinovac’s Swine Flu Vaccine OK’d in Mexico
Mycenax Finishes Phase II Trial of Biosimilar Drug
Hutchison MediPharma Starts Phase I Trial of Auto-Immune Candidate
Hutchison MediPharma Says HMPL-004 Meets Trial Endpoints
China Medical’s FISH Probe for Leukemia Approved
Oculus Receives China OK for Animal Wound Product
Shanghai Biolaxy Given SFDA OK for Oral Insulin IND
China Sky One Close to Approval on Two Diagnostic Tests
Tianyin Pharma Announces Two TCM Product Approvals
Bayer Schering Receives SFDA Approval for MS Drug
Merck KGaA Starts China Trial of Cancer Vaccine
Astellas Given SFDA Approval for Overactive Bladder Treatment
Sinovac Files to Begin Trial of Vaccine for Hand, Food and Mouth Disease
TCM Treatment Announced for H1N1 Flu
China Aoxing Completes Trial of TCM Product for Menstrual Pain
3SBio Files to Begin Trial of Anemia Drug
China Pharma Holdings Seeks Approval of Generic Hypertension Drug
Sinobiopharma to Launch ACE Inhibitor
NeoStem Receives SFDA Approval for Proton Pump Inhibitor
China Aoxing Completes Trial of Pain Drug
Bayer Schering to Conduct Phase IV Hypertension trial in China
Novo Nordisk Awaits China Approval of Type 2 Diabetes Treatment
NeoStem’s Eyre Subsidiary Approved to Use New Manufacturing Facility
Simcere Given OK by SFDA for Flu Drug Relenza
OrbusNeich Begins China Clinical Trial of Bio-Engineered Stent
ChinaBio™ Golf Shirt - Men's (Image)
ChinaBio™ Golf Shirts - Women's (Image)
In My Opinion
Rumors: SFDA to Speed INDs / US FDA OK with China Data
"It's a Relationship Business"
Angel Investing in Life Science: The Best of Times, the Worst of Times
Food and Drug Safety: Who is Really Responsible?
Could War with China be Imminent?
Follow-on Biologics Revisited: Who’s on First?
Early Stage Biotechnology Investing – At China Speed
Behind the Great Wall of China Biotech
California Surfing – Silicon Valley vs. San Diego
Quake Rocks China, Biotech Rocks On
FDA's Presence in China - A Momentous Event
In My Opinion: China vs. the Economy - Is it China's Time?
China’s Opportunity to Create Mega-Clusters
SFDA What's New
Seminar Registration - Unknown Error - CN
Seminar Registration - Unknown Error
Seminar Registration - Missing Fields - CN
Seminar Registration - Missing Fields
Seminar Registration - Thanks - CN
Seminar Registration - Thanks
Size Conversion Chart
Subscriber Discounts
ChinaBio® Golf Shirts - Women's
ChinaBio® Golf Shirts - Men's
Site Features
Login Help
RSS Feeds
ChinaBio Store
About Us
Archived Articles
The Day in Review: FDA Rejects Oporia From Pfizer
FDA Surprises: Panel Recommends Tarceva for Pancreatic Cancer
The Day in Review: FDA Panel Recommends Revlimid from Celgene
Tarceva Misses in Pancreatic Cancer
AlgoRx in Takeunder with Corgentech
Alcon Hurt by Failure of Wet AMD Drug. Who Gets Help?
La Jolla Pharma Hit by FDA. Will It Survive?
Alpharma Launches Generic Neurontin, Despite Patent Infringement Suit
Eyetech Rallies on Alcon Setback. Can It Deliver a Blockbuster Drug?
Prana Reports Positive Trial Results in Alzheimer's Drug
Biggest Biotech Winners and Losers During Q3
J&J Delivers, Stock Rallies
Vioxx: Big Pharma Needs New Business Model
Bad News Rising -- The Week In Biotech
Theravance's Unusual Relationship with Glaxo
Genentech: Overpriced?
Chiron Takes Hit on Loss of Flu Vaccine
Medarex Gets $110MM from Pfizer
Par Receives Tentative OK for Pain Drug
Tarceva Effective Against Pancreatic Cancer
Can Schering-Plough Find Its Way?
Onyx Drug Enters Phase I Cancer Trial
Investors Like Atherogenics' Lipitor Competitor
Nastech Up 70% on Merck Obesity Deal
Idea Launches Pain Trial
Merck Pulls Vioxx: The Impact
Advanced Neuro Makes Offer for Cyberonics
Pfizer Loses Generic Battle Against Alpharma
Cel-Sci Jumps on Multikine Link to Cholesterol
Genentech and OSI Launch New Tarceva Trial
Warning Issued on Antidepressants
Big Day for Encysive
AstraZeneca's Exanta Hit by FDA
SuperGen Gets Help from MGI Pharma
Merck's Troubles Keep Coming
The Hot New Field Of Neural Stimulation
Guidant Beats J&J's Stent to Market
MedImmune, Once a High Flyer, Stumbles
Forest Labs' Neramexane Trial Fails
Gilead Rises on HIV Interim Results
J&J Receives Good News on Stent
Corgentech Gets Whacked after Releasing Data
Outsourcing Drug Development: Are We There Yet?
Roche Invests in Ambit Biosciences
Cyberonics Mulls FDA Appeal
Anti-angiogenesis May Not Be Silver Bullet
Avanir Rises on Neurodex Data
Agilent Wages Gene Expression War
Merck's Vioxx Increases Heart Attack Risk
Possis Crashes on Trial Results
Biotech Moves Ahead of Major Indexes
Biotechs Drop Genomics Moniker
GeneLogic Struggles to Survive
Boston Scientific's Loss Is J&J's Gain
The Day in Review: Biotech Slides Lower
Boston Scientific Taxus Troubles Mount
Neurome Acquires Digital Gene
Xoma Gives up on Acne Drug
Mylan's Generic Patch Stopped
Invitrogen Nears 52 Week Low
Merck Continues Attack on Cancer
Personalized Medicine: More Practical Issues
Schering-Plough Positioned for a Pop
Cancer Treatment: Traditional Approaches (Part 2)
Pharmion Raises Another $221 Million
ILEX-Genzyme Merger A Good Thing
Biotech to Beat the Summer Blahs
BioSante Rises on LibiGel Study
Merck Attacks Cancer with Vertex
Genzyme Beats Expectations, Jumps 12%
Genentech Racks Up Solid Quarter
Momenta and Senomyx IPOs Jump
OSI and Genentech Sign Tarceva Agreements
Drugs and Politics: It's Election Time
Cancer Treatment: Traditional Approaches (Part 1)
Orchid Jumps on Contract with U.K.
Research Back in Fashion
Cyberonics' VNS Treats Depression
ASCO: Despite the Sizzle, It Fizzles
Biotech IPOs Slow Again
BIO 2004: Not with a Bang, but a Wimper
Abbott In Hot Water Again
Dr. Reddy's Hit by Bad Quarter
Biotechs to Benefit from Project Bioshield
Personalized Medicine: Wishful Thinking? (Part 2)
BIO 2004: Opening Reception Quiet
ViroLogic and Aclara Merge - Sort of
ASCO: Big Announcements Expected
Surge of Late May IPOs
Pharmion Has Much More Upside
Vicuron Plummets - A Buying Opportunity?
Pharmion Surges on FDA approval
Bristol-Myers Squibb Withdraws Serzone
Encysive: A Quiet High Flyer
UCB Pharma Buys Celltech
The War On Cancer (Part 3)
The War On Cancer (Part 2)
M&A Watch
What's Wrong with Onyx?
Andrx Rises on Success of Generics
Dr. Reddy's vs. the World
Amgen Presents Data at ASCO
Personalized Medicine: Wishful Thinking? (Part 1)
Genentech: Which Way Goes DNA?
Abbott Labs Reports In-line Q3; Is the Worst Over for the Company?
Onyx Drug on Approval Fast Track
Memory: IPO Up 20%
SuperGen: As Bad As It Seems?
Why Amgen and Tularik?
Human Genome - The End of an Era
Biomira: Cancer Vaccine Coming?
Xenogen: Exciting Platform Play
State of the Industry
Favrille Files for IPO
Applied Bio vs. Affymetrix
The LION of Bioinformatics
Abbott Labs Under Pressure
The Day in Review: Vical Up On HIV News
Genentech: It Keeps Going and Going...
J&J Rises On Strong Q2 Results
Agilent Supports Biomedical Education
Sanofi-Aventis: Merger Drama Continues
J&J: Doing Well Except for Anemia
Abbott's Mad Cow Test Doesn't Help Stock
UCB: Another Takeover Target?
Cyberkinetics' Testing Brain Implant
Prana Soars On Alzheimer's News
Regeneron Initates Cancer Trials
Orchid Jumps on Scrapie Announcement
Teva: The Lure of Generics
Onyx Continues to Look Good
VC Watch
Prana: The Force is With Them
IPO Review - Q1 2004
Affymetrix: Down Amid Confusion
Drug Prices: Does Higher Mean Better?
Allos and Genta-Aventis Drugs Fail
Biotech IPO Performance
Xenova Revises Brain Cancer Trials
Blockbuster Drugs: Good or Bad? (Part 2)
Immune Response Soars 30%
The War On Cancer (Part 1)
OSI: Is the 139% Rise Justified?
Barrier and Cytokinetics Have Strong IPOs
Blockbuster Drugs: Good or Bad? (Part 1)
Another Biotech Boom?
Encysive Focuses on High Value Niches
ParAllele vs. Affymetrix: Who's the Real Winner?
A Look Back at June in Biotech
Genentech's Avastin: How Big Is the Risk?
Abbott Under Fire From Protestors
IPO Pipeline
A Closer Look at Eyetech's Macugen
Genelabs Drops 65% on Failed Phase III Trial
Recent IPOs: Who's winning? Who's losing?
Bextra Linked to Heart Attack and Stroke
Early August Sees Big VC Rounds
New Drugs For Colorectal Cancer
Abbott Gets OK For Carotid Stent
The Day in Review: Another FDA Advisory Panel
The Day in Review: Clinical News Aids Rise in Biotech
The Week in Review: FDA Panels In An Approving Mood
Athenagen raises $5.7 Million in Series A
The Day in Review: Stem Cells Raise Hopes Again
The Day in Review: Tysabri Files for FDA Re-Approval
Good News for Eyetech All Around
Antipsychotic Drugs Are All Pretty Much the Same
The Day in Review: Biotech IPO Is Pulled
New Approaches to Prostate Cancer
The Day in Review: An Unusual Black Eye For Avastin
The Week in Review: Biotech is Storm Tossed
CoTherix Gets IPO Done, Barely
The Week in Biotech: Oil and Troubled Water
Forest Labs' Earnings Up 61% in Q2
Celgene's Q3 Beats, Drops, Rolls
Flu is Deadly. Who's Fault is the Current Mess?
Pain Drugs: Problems and Opportunities (Part 1)
Pain Drugs: Problems and Opportunities (Part 2)
The Day in Review: Biotech Drops Back
Johnson & Johnson Gains on FDA Approval of Disk
The Day in Review: Oil Ignites Biotech
Celgene s Q3 Beats. It s not cheap, but we like it.
Flu is Deadly. Whose Fault is the Current Mess?
Biogen Idec's Breakthrough MS Drug
The Week in Biotech: Sinks for Third Week in a Row
Troubled aaiPharma Climbs 80% Today
WSJ: Merck Covered Up Vioxx's Problems
The Day in Biotech: Cheap Hydrocarbons Move Market Higher
Amgen Gets EU Approval for Mimpara
Four Biotechs Among Briefing.com's Most Highly Shorted
The Day in Biotech: Stocks Close Slightly Higher
AstraZeneca Posts Good Q3
Big Pharma, Big Problems
The Day in Biotech: Flat Trading
Novartis' Femara Gets Wider Approval
Onyx's Setback & Why We Still Like It
The Week in Biotech: Solid Gains
The Day in Biotech: Restrained Trading
The Day in Biotech: Kerry Krash?
The Day in Biotech: Biotech Gets Bush Push
More on Genentech's Avastin
Medical Marijuana Gains Ground in the West
The Day in Biotech: A Powerful Rally
Brit Journal Criticizes FDA over Vioxx
Pain Drugs: Problems and Opportunities (Part 2)
The Day in Biotech: Biotech Outperforms Market
The Week in Biotech: The Past Persists for Pharma
Vical Rises on Positive Phase II Results
Medarex Gains on another Big Deal, Despite Losses
The Day in Biotech: Payback Time for Biotech
NitroMed's Race-Specific Drug
Surrogate Markers
The Day in Biotech: Virtually Unchanged
The Day in Biotech: Ho-Hum
Who Gains From the Election?
Encysive's Thelin Gets "Orphan Drug"
Ventiv Health Profits by Marketing Drugs
The Day in Biotech: Solid, Steady Gains
Cervical Cancer Vaccine Found Effective
Is Affymetrix Ready to Rally?
OSI Raises $387 Million
The Day in Biotech: Biotech Takes One on the Chin
Medarex on the Verge of the Big Time
The Week in Biotech: Biotech Notches Small Weekly Rise
Pfizer Fights Viagra Fraud with RFID
The Day in Biotech: Biotech Demurely Consolidates
Pain Drugs: Problems and Opportunities (Part 3)
The Day in Biotech: Follows Broad Market Drop
The Day in Biotech: Biotech Flat
Puerto Rico is New Biotech Hub
The Day in Biotech: Biotech Sinks
FDA Approves Tarceva Early, But Hits Vioxx
The Vioxx Curse Spreads
The Day in Biotech: Greenspan Slams Market
Is the Tarceva Slide Wrong?
The Week in Review: Biotech Drops 3%
Is the FDA Conflicted?
The Day in Review: Biotech Narrowly Ekes Out a Win
Featured Company: Ventiv Health Has a Great Niche
More Side-Effect Fallout
Dueling Stem Cell Funds
The Day in Review: Biotech Recovers Midday Losses
Blockbuster MS Drug Gets Approval
The Day in Review: Biotech Up All Day
End of the Line for Genasense?
The Day in Review: Biotech Outperforms
The Week in Review: Biotech Climbs 1%
Swiss Approve Stem-Cell Research
Is Merck a Takeover Target?
Tarceva's Disputed Prospects
The Day in Review: Index Flat But Stocks Move
Promising Technologies 5B: Stem Cell Companies
FDA Panel Recommends Ilex's Clolar
Pain Drugs: Problems and Opportunities (Part 4)
CuraGen's Drug Gets on the Fast Track
The Day in Review: Biotech's Second Big Gain in a Row
Rx Use Keeps Growing
Biomira's Run-up No Surprise to Centient Readers
The Day in Review: Biotech Slips, One Stock Doubles
The Day in Review: Biotech Slides into the Close
The Week in Review: Biotech Up Strong on Week
The Day in Review: Biotech Outperforms
Pfizer's Solid Pipeline
Merck Reduces 2005 Guidance
The Day in Review: Biotech Shows Relative Strength
Introgen's Drug Is Helpful--Will It Be Profitable?
The Day in Review: Biotech Up Again
Applied Biosystems Loses Patent
The Day in Review: Biotech Moves Lower
The Week in Review: Biotech Gains, Broad Market Declines
Nektar Delivers the Drugs
The Day in Review: Biotech Adds On 1%
Abbott Seeks FDA Approval for Xinlay
The Day in Review: Biotech Climbs Following Fed Hike
The Day In Review: Biotech Slumps
FDA OK's Amgen's Kepivance (palifermin)
CancerVax Gets $37 Million from Serono for Canvaxin
The Day in Review: Biotech Strong, Market Weak
OSI Pharma Soars as AstraZeneca's Iressa Disappoints
Pfizer Sinks on Celebrex News
Iressa Loses, Tarceva Wins
The Day in Review: Pfizer's Celebrex Casts Pall over Stocks
The Week in Review: The News Blues
Pharmos Down 70% on Failed Trial
Eyetech's Macugen Gets FDA Approval
Genomics Visionary Joins OneWorld Board
The Day in Review: Biotech Gives Up Early Gains
Aspirin Still Better than Aleve
The Day in Review: The Santa Claus Rally Begins
Remicade: More Approvals, More Warnings
The Day in Review: Biotech Flat as Market Moves Up a Little
Adolor's Stock Crashes as Entereg Fails
Novartis' Enablex Gets FDA Thumbs-Up
The Day in Review: Biotech Closes Week With Gain
The Week in Review: Biotech Moves On Up
The Day in Review: Biotech Takes One on the Chin
The Day in Review: Biotech Soars, Easily Erasing Monday's Loss
Genzyme's Clolar Wins FDA Approval
Featured Company: Protein Design's Rich Royalty Stream
The Day in Review: High-Level Consolidation for Biotech
CoTherix Wins FDA Approval for Ventavis
The Day in Review: Biotech Ekes Out a Gain
Pfizer's Lyrica: Is FDA Approval a Setback?
The Day in Review: Biotechs Lose Ground in Light Session
The Week in Review: Looking Back at 2004
SuperGen Withdraws Orathecin
The Day in Review: January Off to a Bad Start
Stem Cells Help Monkeys with Parkinson's
The Day in Review: Biotech Follows Wall Street Lower
Stem Cells Repair Heart Attack Scars
The Week In Review: Biotech Adds To Its Advance
Biotech Winners and Losers during 2004
The Day in Review: Three-Peat Loss for Biotech in 2005
Genentech Adds Warning Label to Avastin
The Day in Review: Substantial Rise for Biotech
Statins, the C-reactive Protein, and Big Pharma
FDA Deals Schering a Setback on Bonefos
The Day in Review: Biotech Gives Up Early Gains
The Week in Review: Dashed Hopes
The Day in Review: Biotech Outpaces Market as a Whole
ViaCell and Umbilical Cord Stem Cells
The Day in Review: Biotech Outperforms On the Downside
IPO Watch: '05 Update - Slow Going
Mylan-King Merger Coming Undone
The Day in Review: Biotech Ekes Out a Gain
The Day in Review: Biotech Slides Into the Close
The JPMorgan Healthcare Conference: Who's Up? Who's Not?
Featured Company: StemCells
The JPMorgan Healthcare Conference: Key 2004 Drug Approvals
The Day in Review: Biotech Closes Week with Rally
The Coming Paradigm Shift in Cancer
The Week in Review: Another Slide for Biotech
FDA Asks Maxim for Another Phase III on Ceplene
The Day in Review: Biotech Down While Market Climbs
Pfizer's Q4 Numbers: Drat! No Surprises
The Day in Review: Biotech Manages a Small Gain
Is Plavix Less Effective Than Aspirin?
Novartis Misses Its Numbers, But Profits Rise
The Day in Review: Biotech Dragged Lower in Final Hour
ViaCell Prices at Low End, Trades Higher
The Day in Review: Biotech Gives Up Early Gains
The Week in Review: Three-for-Three So Far in 2005
Why is Pfizer Sinking?
Biotech Earnings Due This Week
Money Finding a Home in Biotech
The Day in Review: Big Drop in Biotech
Earnings Reports: Big Pharma Can Still Make Big Money
Protein Design Makes $475 Million Purchase
The Day in Review: Biggest Gain of Year for Biotech
Johnson & Johnson Keeps on Performing
The Day in Review: Biotech Climbs for Second Day in a Row
The Day in Review: More Gains for Biotech
Biotech/Pharma Earnings Today
PerkinElmer Wins Merrill Upgrade
Merck Gets Hit with Double-Whammy
The Day in Review: Biotech is Slightly Lower
The Week in Review: First Positive Week of the Year
HMO Bans Pfizer's Bextra
The Day in Review: Biotech Books a Solid Gain
The Day in Review: Biotech on a Winning Streak
IPO Watch: Favrille, Personalized Medicine and Cancer
The Day in Review: Biotech Lower After Fed Decision
Threshold Pharma and Metabolic Targeting
Controversial Cyberonics Gets FDA Approvable Letter
The Day in Review: Biotech Moves Lower
Onyx's Promising Cancer Drug
The Day in Review: Big Gain for Biotech
The Week in Review: Spectacular Rise for Biotech
Axonyx Gets Whacked Over Phenserine
The Day in Review: Biotech Consolidates After Recent Gains
Pfizer Cancer Drug Shines
The Day in Review: Biotech Consolidates Again
AlgoRx Treats Pain
The Day in Review: Biotech Takes a Beating
The Day in Review: Biotech Slumps Again
Bad News Can (Reversibly) Break Your Heart
The Day In Review: Genzyme Stops Heart Disease Trial
ViaCell: A Lower Risk Stem Cell Play
The Day in Review: Biotech Climbs 1.9%
The Week in Review: Biotech Inclines to Decline
Encysive Surges as Thelin Performs
The Day in Review: Biotech Makes It Two in a Row
Aphton Cut in Half After Insegia Failure
The Day in Review: Biotech Holds On For Small Gain
The Day in Review: Biotech Breaks Winning Streak
Eyetech Misses Its Numbers
Dendreon Says Provenge Increases Survival for Prostate Patients
The Day in Review: Biotech Suffers Late Slide
FDA Panel Votes To Keep Celebrex on Market
The Day in Review: Big Pharma Comes Back from the Dead
The Week in Review: Big Pharma Gets Revenge
Novartis Indulges in Some Generic Thinking
The Day in Review: Biotech Gets Hit Upside the Head
The Day in Review: Biotech Closes In Positive Territory
Whereto COX-2?
The Day in Review: Biotech Gains on Late Rally
Antares Promises Announcement Tomorrow
The Day in Review: Biotech Makes It Three in a Row
IPO Watch: Targacept and IPO Disarray
The Week in Review: Biotech and Caution
Biogen Idec and Elan Pull Tysabri Off Market
The Day in Review: Tysabri Recall Slams All of Biotech
The Day in Review: Biotech Manages a Small Recovery
Chiron Up 10% on Flu License Reinstatement
The Day in Review: Biotech Rides Chiron News Higher
Handicapping Biogen Idec and Tysabri
The Day in Review: Biotech Driven Lower
The Day in Review: Biotech Sinks, Broad Market Swims
The Week in Review: Biotech's Week Ruined by Tysabri
Citing Success, Celgene Ends Revlimid Trial Early
The Day in Review: Biotech Manages a Gain, Though a Small One
Adolor Jumps on Partial Vindication for Entereg
The Day in Review: Biotech Off Slightly in Quiet Trading
The Day in Review: Biotech Suffers Small Loss
CombinatoRx and the Biological Two-Step
The Day in Review: Biotech Marks 5-Year Anniversary of Nasdaq Bubble Quietly
Is Aspirin Next for Age-Related Macular Degeneration?
The Day in Review: Biotech Closes Week With A Loss
The Week in Review: Bubble, Bubble, Toil & Trouble
The Day in Review: Genentech News Brings Biotech Off The Mat
The Day In Review: Biotech Gives Back Some of Monday's Gain
Another Look at Biogen Idec
NitroMed and Personalized Medicine
The Day in Review: Biogen Idec Warning Sends Biotech Lower
The Day in Review: In a Late Surge Biotech Manages a Gain
The Day in Review: Sound and Fury, Signifying Little
New River Pharma: Biotech on the Cheap
The Week in Review: Biotech Rides Genentech To A Gain
Genentech and Roche Gain as Novartis and Schering Drop
Good News for Bayer and Onyx
The Day in Review: Biotech Rises Despite Weak General Market
Nanotechnology and Biotech, Part 1
The Day in Review: Fed Puts the Kabosh on Stocks
The Day in Review: Biotech Makes Gain in Quiet Trading
Guilford Pharma Stops Sedative Trial
The Day in Review: Biotech Keeps a Small Gain
The Week in Review: From Optimism to Pessimism in Three Short Weeks
Ligand Down 20% after Targretin Fails Tests
The Day in Review: Biotech Slides Lower
The Day in Review: Biotech Slinks Into Closing Bell
Corgentech Cut in Half After Phase III Trial Failure
Nanotechnology and Biotech, Part 2
The Week in Review: Lots of Movement But Little Change
The Day in Review: Biotech Stays While Market Plays
Is Tysabri Finished? Another Death Found...
Massachusetts Approves Stem Cell Bill
The Day in Review: Tysabri Dominates Biotech News Again
The Day in Review: Biotech Hits a New 52-Week Low
The Week in Review: Biotech Limps Into 2nd Quarter
The Day in Review: Biotech Slips Lower
First Quarter Roundup
Pfizer's Three-Year Game Plan: CEO McKinnell Comments
The Day in Review: Biotech Makes a Gain
CancerVax Gets Clobbered as Serano Halts Canvaxin Trial
The Day in Review: Biotech Gains A Substantial 1+%
BG-12 From Biogen Idec Effective Against Psoriasis
The Day in Review: Biotech Makes It Three For Three
Pfizer, Bextra and Celebrex: Will COX-2 Debacle End with a Takeover?
The Day in Review: Biotech Strong While Market Slides
The Week in Review: The Biotech Bounce
The Day in Review: Biotech Ends Winning Streak
The Day in Review: Biotech Reverses, Limiting Loss
Featured Company: Affymetrix and Genetic Analysis
Tysabri 2-Year MS Study: The Battle Is Joined
The Day in Review: Biotech Follows Market Lower
Who Cares About Stroke?
The Day in Review: Biotech Succumbs to Market Pressure
Avastin from Genentech Conquers Another Cancer
The Day in Review: Biotech Rides the Avastin Horse
The Week in Review: Biotech Gains By Not Losing
Where to Put Your Money?
Pfizer Hits Its Numbers
The Day in Review: Biotech Lower as Stocks Calm Down
The Day in Review: Acquisitions Help Biotech
The Day in Review: Biotech Manages to Contain Its Loss
Prana Drops Alzheimer's Study
Shire Offers $1.6 Billion for Transkaryotic
The Day in Review: Biotech Soars Higher
Is Millipore a Biomarker for Biotech Industry?
Abbott: Challenges Ahead
The Day in Review: Rumors Ravage Biotech
The Day in Review: Late Surge Brings Biotech Almost Positive
Herceptin Delivers Another Triumph to Genentech
The Day in Review: Genentech Drives Biotech Higher
The Day in Review: Small Loss for Biotech
Is There a Second Act for Tysabri?
The Day in Review: Market Pressures Push Biotech Lower
The Day in Review: Oil Slide Sends Biotech Higher
Celera Gives Away Genome Information
The Week in Review: Volatility? What Volatility?
The Day in Review: Biotech Makes Solid Gain
The Day in Review: Biotech Books Third Up Session in a Row
Inflammation Is Not Just About Drugs, Part I
Renovis and AstraZeneca (May) Have a Stroke Drug
The Day in Review: Biotech Climbs Again
Clinton Weighs In on Obesity and Junk Food
Avidia: Cashing In on the Antibody Craze
The Day in Review: Biotech Takes First Loss in a Week
Celator Raises $40 Million for Combination Chemo
The Day in Review: Biotech Takes a (Small) Breather
Inflammation Is Not Just About Drugs, Part II
The Week in Review: Biotech Gains 2% On the Week
What To Expect From ASCO?
The Day in Review: Biotech Moves Higher While Market Slides
The Day in Review: Biotech Adds On 1%
Conforma: Targeting Heat Shock Protein to Fight Cancer
Weak IPO Market Spells Trouble
The Day in Review: Three in a Row for Biotech
Cellerant Raises $16 Million for Stem Cells
The Day in Review: Market Pressures Force Biotech Lower
Cephalon Acquires Salmedix
The Week in Review: Biotech Displays Relative Strength
ASCO News: Success and Failure in Drug Trials
Big Pharma Moves into Cancer
The Day in Review: Good Gain for Biotech
Tranzyme Pharma Creatively Raises $32 Million
AstraZeneca Keeps Pursuing Lung Cancer
Nanotechnology and Biotech, Part 3
The Day in Review: Biotech Squeezes Out a Gain
Zelos Therapeutics Raises $42.5 Million in Series B
The Day in Review: Biotech Rises Again
Cyberonics Hit On Senate Investigation News
The Day in Review: A Subdued Gain for Biotech
Promising Technologies, Part 1: Monoclonal Antibodies
GeminX Raises $50 Million for Apoptosis Drug
The Day in Review: Biotech Takes a Small Loss
The Week in Review: Biotech Continues To Rise Off April Lows
Promising Technologies, Part 2: Gene Therapy
The Day in Review: Biotech Begins Week With a Rally
Genentech Scores with Lucentis
Oxagen Ltd. Raises $60 Million in Series B
The Day in Review: Biotech Rises On Genentech Success
Phenomix Raises $40 Million in Series B
The Day in Review: Biotech Gives Up Some of its Recent Gains
The Stem Cell Wars
The Day in Review: Biotech Regains Its Winning Ways
Cylene Pharma Raises $26.3 Million in Series B
The Day in Review: Biotech Tacks on Another 10 Points
The Week in Review: The Biotech Roll Keeps Rolling
The Funding Crisis in Biotech
Promising Technologies, Part 3: Gene Silencing
The Day in Review: Biotech Gives Some Back
Affymetrix Acquires ParAllele for $120 Million in Stock
The Day in Review: Back in Rally Mode
The Day in Review: Biotech Gains in Quiet Trading
XenoPort Raises $53 Million in IPO
Medicare Expected to Introduce Pricing Cuts
The Day in Review: Biotech Takes Biggest Loss In a Month
IPO Watch: May Continues Slow Run
The Week in Review: Biotech Takes a Breather
The Day in Review: No Bounce for Biotech
Somaxon Pharma Raises $65 Million
Devgen Raises $37 Million in European IPO
The Day in Review: Biotech Sinks Again
Stem Cells Improve Heart Failure in Humans
The Day in Review: Biotech Takes Another Loss
Osiris Therapeutics Raises $50 Million
Will a Blood Test Allow Tysabri to Return to Market?
The Day in Review: Biotech Books a Solid Gain
Verus Pharma Raises $98 Million in A Round
The Day in Review: Late Surge Brings Biotech Off Lows
The Week in Review: Biotech Gets A Small Trim
Connetics Takes Hit After FDA Rejects Acne Drug
The Day in Review: Biotech Takes Another Small Loss
Synta Pharmaceuticals Withdraws IPO
Promising Technologies, Part 4A: Stem Cells
The Day in Review: Biotech Ends With a Gain
Promising Technologies, Part 4B: Stem Cells
The Day in Review: Biotech Slips a Little Lower
NeurogesX Starts Phase III Pain Trial
Pfizer Offers 84% Premium for Vicuron
The Day in Review: Another Thursday Gain for Biotech
Gentium S.p.A. Does IPO
Vertex and Merck Launch Third Cancer Trial
Sanofi-Aventis Loses Lovenox Patent Fight
Genentech Positioned for Unimpeded Growth
The Day in Review: Another Good Day for Biotech
The Week in Review: Biotech Recovers Two-Week Loss
Therion Biologics Secures $30 Million
First Cannabis Drug Goes On Sale in Canada
The Day in Review: Biotech Makes Third Gain in a Row
Merck KGaA Wins Key Patent Victory
Clinical Data Acquires Genaissance in All-Stock Deal
The Day in Review: Biotech Gives Back Some Recent Gains
Johnson & Johnson Wins First Round Over Boston Scientific
The Day in Review: Biotech Slumps Again
Promising Technologies 5A: Stem Cell Companies
The Week in Review: Biotech Corrects by 1.4%
The Day in Review: Biotech Follows Market South
ISSCR Shows Stem Cells Are Hot
The Day in Review: Biotech Plays While Market Pays
Promise v. Risk: The Stem Cell Meeting in San Francisco
The Day in Review: Biotech Starts Week With a Small Loss
New Frontiers in Diabetes at ADA Meeting
The Day in Review: Biotech Soars Higher
Corautus Raises $23 Million in Private Placement
The Day in Review: No Follow-Through For Biotech
Barrier Crashes as Hyphanox Fails Its Phase III
What Levin's Exit Means to Millennium
The Day in Review: Fed Move Sends Biotech Lower
The Day in Review: Biotech Ends the Week With a Gain
The Week in Review: First Half of 2005 in Biotech
Europe Ahead in IPOs
The Week in Review: Highest Weekly Close for Biotech in 2005
The Day in Review: Biotech Adds More Than 1%
New Drug from Human Genome Sciences: Investment Potential?
The Day in Review: Biotech Shows Relative Strength
Ganymed Raises EUR 14.4 Million
StemCells-ReNeuron Deal: Endorsement for Conditional Immortalization
The Day in Review: Biotech Soars On Amgen Rise
StemCells-ReNeuron Deal: Gene Manipulation and Stem Cells Intersect
The Day in Review: Biotech Gains Almost 70 Points
The Day in Review: Biotech Climbs Modestly
Genentech Beats Expectations in Q2
The Day in Review: Biotech Closes Near 2005 High
ReNeuron Plans IPO - Again
Primera Biosystems Raises $11 Million for Gene Expression
The Day in Review: Biotech Takes A Small Loss
Promising Technologies 5C: Stem Cell Companies
The Day in Review: Biotech Flat on the Week
GlaxoSmithKline Breathes Easier on Advair
Another Stem Cell Company Will Begin Trading on Monday
The Day in Review: Biotech Shows Gain for 2005
The Day in Review: Biotech Keeps The Momentum Going
The Week in Review: CBT 200 Rises 3% To A 2005 High
The Day in Review: Biotech Gives Back Some Gains
Roche Combines Amgen Valuation with the Growth of Genentech
The Day in Review: Biotech Makes Gain Before Amgen Earnings
Amgen's Q2 Blows Out Expectations
Genomic Health Files for High Profile IPO
Trouble for Merck in Vioxx Lawsuit
Ilypsa Raises $36 Million For Kidney Drugs
The Day in Review: Amgen Spurs 142 Point Rise In CBT 200
Adams IPO Rocks
The Day in Review: Biotech Holds Gains While Market Slides
The Day in Review: Biotech Gives Back Some Gains
The Week in Review: Biotech Rolls 10% Higher in July
Will Generics End the Biotech Boom?
The Day in Review: Biotech Backs Off a Little
The Day in Review: Biotech Rises Sharply
Genitope Crashes On MyVax News
The Day in Review: Biotech Adds On Another 16 Points
Stem Cells Challenge Another Long-Held Belief
The Day in Review: Biotech Gains Again
Big Pharma In Fortune's Most Profitable List
The Mumbo-Jumbo of Cancer Trial Results
The Day in Review: Biotech Takes A Small Loss
Frist Support Puts Life in Stem Cell Shares
The Week in Review: Biotech Keeps July Rally Alive
Promising Technologies 5D: Stem Cell Companies
The Day in Review: Biotech Tops Old High
The Day in Review: Biotech Keeps Its Upward Momentum
Protein Design Labs Partners With Biogen Idec
The Day in Review: CBT200 Hits New Record Again
The Day in Review: Biotech Gives Back Some Gains
Featured Company: The
New
Protein Design Labs
Advanced Life Sciences Holdings Prices Below Range
The Week in Review: New High Set During the Week
IPO Watch: 2005 Biotech IPOs Strong
The Day in Review: Biotech Consolidates Again
Can Biogen Idec and Elan Bring Tysabri Back?
The Day in Review: Biotech Posts a Solid Gain
Another Successful IPO: Coley Pharma
The IPO Class of 2003-4: How Successful Was It?
The Day in Review: Positive Coley IPO Not Enough for Biotech
The Day in Review: Big Gain for Biotech
The Day in Review: Biotech Slides Into the Weekend
The Week in Review: Biotech Hovers, Just Below the High
ImClone and UCB Sign Anti-angiogenesis Pact
The Day in Review: Agilent Leads Biotech Higher
The Day in Review: ViroPharma Shines as Biotech Slips Lower
The Day in Review: Biotech Takes A Small Loss
Encysive Pharma, Quietly Rising
Myogen Soars on Hopes for New Blood Pressure Drug
The Day in Review: Myogen Pulls Biotech Higher
Swiss Use Fetal Stem Cell Tissue to Repair Wounds
Merck Loses All Points in Vioxx Trial
The Day in Review: Vioxx Verdict Keeps a Lid On Biotech
The Week in Review: 2005 High for Biotech
Lung Cancer, An Often Ignored Killer
Panacos Drug Effective Against HIV
The Day in Review: Biotech Up Slightly on OSI-Eyetech Merger
Amylin Climbs Up on Byetta Success
The Day in Review: Amylin Keeps Biotech Positive
The Day in Review: Biotech Takes A Small Loss
The Day in Review: Novavax and Genaera Are Big Winners Today
Novavax And Its New Vaccine
The Day in Review: FDA Delays Ruling on Morning-After Pill
The Week in Review: Biotech Holds Its Own
The Day in Review: Novavax Continues Its Rise
Vasogen Down After Celacade Failure
The Day in Review: Vasogen Fails Phase III
FDA Set to Rule on Dacogen from MGI Pharma
The Day in Review: Biotech Reaches New High
Pancreatic Cancer - Causes and (Potential) Cures
The Day in Review: Novartis Makes Bid for Chiron
Genentech Adds Warning To Herceptin
The Day In Review: News On Upcoming IPOs
The Week in Review: New Highs For Biotech
Amgen Surges On Additional Manufacturing Capacity
The Day in Review: Protein Design Helps Biotech Hit New High
Exubera and Pargluva In Front Of FDA Diabetes Panel
The Day in Review: Alnylam Signs Major Deal with Novartis
New Drugs Coming For Insomnia
The Day in Review: FDA Panel Approves Diabetes Drug Exubera
The Day in Review: Diabetes Drug Pargluva Wins FDA Recommendation
IPO Watch: Biotech Activity Picking Up
The Day in Review: Hope For Genasense
The Week in Review: Another New Weekly High for Biotech
The Day In Review: Intense Biotech Deal Activity
Diet And Cancer: The Science and the Hype
The Day in Review: Memory Touts Alzheimers Drug
Cell Therapeutics Climbs on Unusual Finding
The Day in Review: More IPO Weakness
The Day in Review: FDA News Hits Several Biotechs
Milnacipran from Forest Labs/Cypress Fails Phase III
The Day in Review: More Biotech IPO Action
Genomic Health IPO Prices at Bottom of Range
The Day in Review: Good Clinical News
Ugly PCR Fights
IPO Watch: Three Biotech IPOs Test the Water
The Week in Review: Good Quarter for Biotech
The Day in Review: Biotech Starts Q4 With a Gain
The Day in Review: CancerVax Decimated On Drug Failure
Which Biotech Stocks Gained the Most in 2005 (So Far)?
Human Genome Science Upbeat On Failed Lupus Test
The Day in Review: Human Genome Fails Lupus Trial
The Day in Review: Biotech Down Sharply
The Day in Review: Biotech Gets Back on Plus Side
The Week in Review: A Pause That Refreshes?
Celgene Drug Delayed
Genentech Reports Better Than Expected Numbers
The Day in Review: Antigenics Jumps On News
BioCryst Rising on Bird Flu Fears
The Day in Review: Biotech Falls Despite Genentech
Agendia BV Closes Second Round
Nobel Prize for Medicine Highlights Conflicts of Interest
The Day in Review: Biotech Slips Lower
It's Fund Raising Time Again
The Day in Review: J&J Sues Amgen
The Day in Review: Another Recommendation for Exubera
The Week in Review: A Little Blue Sky for Biotech?
Vaccine Makers Deserve a Second Look
IPO Watch: Predix Pharma
The Day in Review: Biotech Slips A Little
Biotech Exchange Traded Funds
The Day in Review: Adding Tarceva No Help For Avastin
Gilead Sciences Reports Higher Revenues and Earnings
Johnson & Johnson Raises Its Outlook
Ten Largest Biotechs and Pharma
The Day in Review: Arena Reports Positive Diet Data
Amgen Takes Hit On Earnings Report
Pfizer Cuts Forecast
The Day in Review: Diabetes Drug Pargluva Attacked
Roche Will Sublicense Tamiflu
The Day in Review: Cephalon Gets Approvable Letter for ADHD
The Week in Review: Will Biotech Have an Average Year?
Orencia From Bristol-Myers Squibb Has Huge Potential
The Day in Review: Biotech Books a 2% Gain
Promising Technologies Part 1B: Monoclonal Antibodies with Payloads
The Day in Review: Biotech Gains Again
Who's Who In The Vaccine Business
The Day in Review: Positive Data for Rituxan
Amylin Pharmaceuticals Disappoints
The Day in Review: Disappointing Earnings Lead Biotech Lower
Largest Biotech and Pharma Companies
The Day In Review: Bristol-Myers Squibb Pulls Pargluva
The Week In Review: Biotech Weathering Q3 Earnings Season
Venture Capital Easier To Get
The Day In Review: Chiron Buyout Leads Biotech Higher
Novartis Offers $5.1B For Remaining 58% Of Chiron
More and More Vaccine News
The Day In Review: Nabi Gets Decimated
The Day In Review: J&J Backing Away From Guidant Deal
Panitumumab from Amgen and Abgenix Posts Strong Data
The Day In Review: Drug News Lifts Biotech
The Day In Review: Biotech Ends Strong Week With A Gain
The Week In Review: Big Week For Biotech
The Day In Review: Guidant Sues J and J Over Merger
The Day In Review: More Good Data for Lucentis from Genentech
D-Pharm Continues Phase IIb In Stroke
Featured Company: Arena Pharma Eyes Big Markets
The Day In Review: Biotech Test News
Pain Therapeutics Inks Remoxy Deal with King Pharma
The Day In Review: Roche Promises Stunning Arthritis News
The Day In Review: DeCODE Finds A Heart Attack Gene
A Look At R&D Investments And Returns
The Week In Review: Biotech Books A New High
BioNovo: Women's Health And Cancer
Pfizer Lipitor Gamble Fails, But Not Completely
The Day In Review: Bristol-Myers Releases Drug News
Who Will Buy Serono?
The Day In Review: Pfizer Finds A Smoking Gun
Big Win For ImClone
The Day In Review: Gilead Settles With Roche
The Day In Review: Does Tamiflu Cause Serious Side Effects?
Chinese Company Wins Approval For Abandoned Onyx Drug
The Day In Review: FDA Rules For Tamiflu
The Week In Review: Biotech Makes Another All-time High
Leptos Biomedical, Neurostimulation For Obesity
Incyte Signs Monster Deal with Pfizer
The Day In Review: FDA News And A Big Drug Deal
The Pain Therapeutics Rollercoaster
The Day In Review: Wyeth Wins Panic Disorder Approval
The Day In Review: Alexion Slumps on Failed Test
Are You Overweight When Everyone Else Is Too?
The Day In Review: Trimeris Needs Another Test For HIV Drug
The Week In Review: Biotech Scores Fifth Gain In A Row
Swiss Approve 5-year GM Food Moratorium
Merck On The Skids
The Day In Review: American Pharma Simplifies Corporate Structure
The Day In Review: Intermune Gets $135 Million For Hepatitis Drug
BioCryst Licenses Immune Suppressant To Roche
Acomplia from Sanofi-Aventis Puts Cannabis To Work
The Day In Review: Drug Deals Abound
Axokine From Regeneron Was Supposed to Be a Blockbuster Obesity Drug
The Day In Review: Rigel Drops By 63% On Failed Test
Ventiv Health Likely To Keep Growing
IPO Watch: Two Winners and Two on Deck
The Day In Review: Inspire Pharma Must Still Prove Dry Eye Drug Works
The Week In Review: Biotech Year-End Rally Takes A Breather
Is Ghrelin A Silver Bullet For Obesity?
The Day In Review: Boston Scientific Makes Bid For Guidant
The Day In Review: Big Pharma Licenses Drugs From Biotech
The Day In Review: First Reports From ASH Conference
The Day In Review: Glaxo Buys ID Biomedical
BioNovo Reports On Phase I Study
IPO Watch: Voyager Pharma Targets Alzheimer's
The Day In Review: Merck In More Hot Water For Vioxx
The Week In Review: More Pause For Year-End Rally
Results Announced At 2005 ASH Conference
The Day In Review: Ambrisentan News Sends Myogen Higher
Some Drugs Actually Save You Money
The GDNF-Parkinson Story Continues
The Day In Review: Insmed Wins Approval For Growth Drug
An Obesity Overview
The Day In Review: Amgen Buys Abgenix
Amgen-Abgenix Merger Makes Sense
The Day In Review: Merck Goes On Offense
The Day In Review: Novartis Dumps Statin Drug Development
The Week In Review: Why Biotech Backed Off
The Day In Review: Nexavar From Bayer/Onyx Gets FDA Approval
Sangamo Reports Success Using ZFNs To Fight Aids
The Week In Review: Biotech Backs Off Slightly
Hypnion Raises Additional $20 Million For Insomnia Drugs
Pfizer Rallies On Favorable Lipitor Ruling
The Day In Review: Novartis May Add to Vaccine Franchise
Genzyme Picks Up Gene Therapy Business From Avigen
The Day In Review: MGI Pharma Surges On Trial News
Cephalon Jumps After Settling Generic Provigil Suit
The Day In Review: More Big Pharma/Biotech Deals
The Day In Review: AstraZeneca Makes Another Acquisition
The Week In Review: Biotech Threatens All-Time Highs
Stem Cell Company Osiris Gathers More Cash
The Day In Review: NeoPharma Gets Good News On Brain Cancer Drug
Biotech Mutual Funds - An Interesting Investment Vehicle
Celgene Gets Revlimid Approval, Finally
The Day In Review: Biotech Deals And Approvals
The Day In Review: Alkermes/Cephalon Alcohol Drug Gets Approvable Letter
The Day In Review: Biotech Notches 10% Gain In 2005
The Week In Review: After A Bad Start, Biotech Nails Down A 10.5% Gain In 2005
Some Big Biotech Growth In 2005
The Day In Review: Pain Therapeutics Gets $150 Million Payment From King
The Day In Review: FDA Allows Test of Cannabis Pain Killer
Sector Review: Monoclonals In 2005
The Day In Review: Two Vaccines from Big Pharma Effective Against Rotavirus
The IPO Year of 2005
The Day In Review: Biotech Gains In First Week Of 2006
How Did The Biggest Biotechs/Pharmas Fare In 2005?
The Week In Review: Biotech Begins 2006 With A Win
IPO Watch: SGX Tests IPO Waters, EpiCept Avoids Them
The Day In Review: Biotech Hits Historic Highs
Day One at JPMorgan Healthcare Conference
Sales For Avastin From Genentech Miss Estimates
The Day In Review: Will Novartis Buy Serono?
Day Two At JPMorgan Healthcare Conference
The Day In Review: Valentis/Theravance Soar On Trial News
Day Three at the JPMorgan Healthcare Conference
The Day In Review: Mylan Does A Deal With Forest Labs
Day Four At The JPMorgan Healthcare Conference
Winners And Losers At The JPMorgan Conference
The Day In Review: Pfizer Buys Out Exubera Partner
The Week In Review: Biotech Runs In Place
Can Wyeth Keep Rising?
The Day In Review: Genentech Back On Offense
The Day In Review: Generic Challenges To Big Pharma
Molecular Diagnostics: The New New Thing?
What Is the Next Move In the Guidant Takeover?
The Week In Review: Biotech Now Positive For 2006
The Day In Review: Good Data From Novartis and Dynavax
The Day In Review: AVI May Have New Flu Drug
The Week In Review: Down Last Week, Biotech Keeps Small 2006 Gain
Hepatitis: The Problem And New Drugs In Trials
The Day In Review: Tysabri Edging Toward FDA Decision
Biotech Companies Classified By Specialty
The Day In Review: ImClone Puts Itself Up For Sale
The Day In Review: Boston Scientific Wins The Guidant Battle
IPO Watch: SGX Pharmaceuticals
The Bionic Baby Boomer
The Day In Review: Amgen Keeps A Lid On Biotech
IPO Watch: Altus Pharmaceuticals
The Day In Review: Pfizer Gets Exubera Approval From FDA
Pfizer's Exubera Inhaled Insulin Approved In Europe And US
The Week In Review: Amgen Drags Biotech Lower
Hip Hip Hooray: The Hip Replacement Boom
The Day In Review: ISTA Expands Pain Drug Indication
Is St Jude Medical The Next Takeover Target?
The Day in Review: Biotech Rides Sepracor Higher
The Day In Review: Amgen Powers Biotech Higher
IPO Watch: Valera Pharmaceuticals
The Day In Review: Cephalon Soars After Preventing Generic Provigil
IPO Watch: Iomai
The Day In Review: InterMune Stops Trial, Stock Slumps
Low Fat Diets Do Not Work
The Week In Review: Biotech Drops Fourth Week In A Row
The Day In Review: QuatRx Files For IPO
Breast Cancer The Third Most Deadly Cancer
The Day In Review: Vertex Rises On Hopes For Hepatitis C Drug
Adolor Soars On Positive Entereg Results
The Day In Review: Pfizer May Sell Consumer Division
The Day In Review: Martek Gains On Higher Guidance
San Francisco Stem Cell Conference
The Day In Review: Diet Drug From Amylin Wins By Losing
The Week In Review: Biotech Slithers Lower
IPO Watch: Acorda Therapeutics Targets MS
The Day In Review: Genentech Suspends Avastin Trial Temporarily
A Closer Look At HIV Drugs
The Day In Review: AstraZeneca Withdraws Exanta
The Day In Review: FDA Allows Tysabri To Restart Trials
Caliper Buys Xenogen For $80 Million
The Day In Review: Hemispherx Claims Progress Against Avian Flu
Calcium Supplements Do Not Work Either
The Day In Review: Acomplia From Sanofi-Aventis Approvable (But Not Approved)
Axcan Hit Hard On Itopride Failure
The Day In Review: Pfizer Gets Approval For Eraxis
The Day In Review: CombinatoRX Dumps Psoriasis Drug
Does Stress Really Cause Cancer?
Forget Glucosamine And Chondroitin, Take Celebrex Instead
The Day In Review: Zostavax From Merck Delayed
Molecular Medicine Tri-Conference
The Day In Review: Biotech Hits New High
The Day In Review: Bristol-Myers Squibb Wins Approval of Ensam
Platinum Cancer Drugs: New Directions
Stem Cell Therapy Fails Heart Attack Test
The Day In Review: Rituxan From Genentech/Biogen Idec Approved For Arthritis
The Day In Review: ImClone Adds Indication for Erbitux
IPO Watch: Alexza Pharmaceuticals
The Day In Review: Celgene Wins Priority Review For Revlimid
The Week In Review: New Biotech High, But No Follow-Through
The Day In Review: Cortex Climbs 33% On ADHD Data
FDA Proposes Tysabri Restrictions
The Day In Review: Cubist Adds Indication To Cubicin
FDA Panel Recommends Re-Approval For Tysabri
The Day In Review: Alexza Stages Its IPO
The Day In Review: Vertex Reports Positive Arthritis Drug News
The Day In Review: Preos From NPS Pharma Gets Approvable Letter
The Week In Review: Biotech Trends Lower
Two Different Takes On The Myogen/Glaxo Deal
The Day In Review: German Merck Offers To Buy Schering
Does Ambien From Sanofi-Aventis Cause The Munchies?
The Day In Review: Biotech Climbs Toward Highs
Parexel Managed Trial Goes Horribly Wrong
The Day In Review: PharmAthene Uses Reverse-Merger To Come Public
The Day In Review: BioMarin Announces Phase III Success
The Day In Review: Genentech Forecast Drives Biotech Higher
The Week In Review: Biotech Gets Highest Weekly Close
Could A Flu Pandemic Happen Here?
The Day In Review: Hepatitis Drug From Valeant Fails Test
BiDil From NitroMed Gets No Respect
The Day In Review: Sanofi/Bristol Climb On Plavix Settlement
The Day In Review: FDA Committee Nixes Sparlon From Cephalon
Shifting Fortunes At Cephalon
The Day In Review: Troubled Trials Dominate News
The Week In Review: Biotech Gives Back Some Gains
Shocker: FDA Wants More Thelin Data From Encysive
The Day In Review: Sanofi-Aventis Adds To Generics Business
Recent IPO SGX Soars On Novartis Deal
The Day In Review: Deals Dominate the News
Guidant And Its Never Ending Quality Issues
The Day In Review: Cambridge Acquisition Keeps Biotech In The Black
The Day In Review: Novartis Inlicenses Idenix Drug For $525 Million
Gene Therapy Alive And Well In Angiogenesis
The Day In Review: ViroPharma Climbs On Maribavir Results
The Day In Review: EpiCept Gains On Ceplene Success
The Week In Review: Biotech Makes Q1 Gain, Barely
The Day In Review: Epix Buys Predix For $90 Million
Another Gene Therapy Spectacular
Biotech Revenues Up 18% In 2005
The Day In Review: Bird Flu Drug Sends Cel-Sci Up 111%
The Day In Review: Vertex Reports Positive Cancer Drug Data
The Day In Review: Arixtra From Glaxo Posts Positive Results
IPO Watch: Omrix Biopharma
The Week In Review: Biotech Takes A Hit
Autologous Cell Therapy Used To Make Bladders
The Day In Review: Pfizer Buys Another Biotech
IPO Watch: Biotech IPOs Still Very Profitable
The Day In Review: Corautus Whacked After Drug Failure
The Day In Review: Genentech Outperforms In Q1
Genentech Earnings Call Manages a Surprise
Does Pharma Invent Disease?
The Day In Review: Biotech IPOs Get Chilly Reception
The Day In Review: Pfizer Buys Drug, Settles Patent
The Week In Review: Biotech Earnings Are Not An Oxymoron
Biogenerics May Be Coming Sooner Than You Think
The Day In Review: Novacea Sets Record IPO Terms
The Day In Review: Amgen Pretty Much Hits Its Numbers
Novartis Biogeneric Gets European OK
The Day In Review: Cephalon Claims Clean Bill Of Health For Sparlon
The Day In Review: Dynavax Gets Creative Funding
Featured Company: Vanda Pharma Rescues Abandoned Drugs
The Day In Review: Gene Logic Takes A Hit
The Week In Review: Earnings, Earnings, Earnings
Mental Training Fails To Slow Brain Decline
The Day In Review: Progenics Takes Control of Cytogen Partnership
The Day In Review: Millipore Buys Seriologicals For $1.4 Billion
Troubles In Device Land
IPO Alert: QuatRx Walks The In-Licensing Path
The Day In Review: SuperGen Drug Disappoints
Is Big Biotech A Bargain?
Neurocrine Blindsided By Indiplon Rejection
The Day In Review: Abraxis Signs Deal With AstraZeneca
The Day In Review: Biomira Cancer Drug Reports Positive Results
The Week In Review: Biotech Posts Small Loss
The Day In Review: Biotechs Update Hepatitis C News
The Day In Review: Vical Flies On Positive Bird Flu News
Older Americans Less Healthy Than Brits
The Day In Review: Biogen Idec Buys Cancer Company Conforma
The Day In Review: Feds Invest $1 Billion In Domestic Flu Vaccines
IPO Watch: Northstar Neuro Prices Above Range
IPO Watch: Novacea Has Cancer Focus
The Week In Review: Biotech Snaps Losing Streak
The Day In Review: Northstar IPO Very Successful
The Day In Review: Pfizer Invests In Monogram
Thermo Electron And Fisher Merge
Ariad Patent Case Means Trouble For Pharma/Biotech
The Day In Review: Merck Gobbles Up Two Biotechs
Vivus Reports Startling Diet Drug Results
The Day In Review: Immunomedics Sells Cancer Drug For $183 Million
The Day In Review: Pfizer Anti-Smoking Drug Chantix Gets Approved
The Day In Review: Threshold Takes Huge Hit On Trial Setback
The Week In Review: An Ugly Week For Biotech
AstraZeneca Pays $1.3 Billion For Cambridge Antibody
Biologics Are Hot Takeover Targets; Who's Next?
The Day In Review: Valeant Wins Approval of Cannabinoid Drug
IPO Watch: BioMimetic Combines Drugs And Devices
The Day In Review: Novartis Gets Positive Data On Rasilez, Again
The Day In Review: Merck Wins Gardasil Recommendation
The Day In Review: Genentech Leads Biotech Higher
The Week In Review: Pharma Loves Biotech; Investors Do Not
The HPV Saga: Not Everyone Wants A Cure
The Day In Review: Vertex Reveals Positive Hep C Data
The Day In Review: Genentech Gets OK To Restart Avastin Trial
The Day In Review: Bird-Flu Companies Jump Higher
Featured Company: Medarex - Deal Or No Deal?
The Day In Review: Encysive Re-Submits Thelin
The Day In Review: FDA Approves 4 Drugs
The Truth About Z Finger Technique
The Week In Review: Biotech Rises In ASCO Anticipation
The Day In Review: CollaGenex Gets Oracea Approval
The Day In Review: Novartis Wins Approval For Generic Omnitrope
It's ASCO Time
The Day In Review: Bioenvision Wins European Approval For Evoltra
The Day In Review: Positive Data From Genentech's Lucentis, Again
Goat-Derived Drug From GTC Bio Gets Recommendation
The Week In Review: Into ASCO
The Day In Review: Tysabri Is Back!
The Changing Face Of ASCO
The Day In Review: Human Genome Inks $507 Million Deal With Novartis
The Day In Review: Novartis Devours Brit Biotech
TorreyPines Does Reverse Merger With Axonyx
The Day In Review: FDA Approves Merck's Gardasil
The Day In Review: PharmAthene Takes Reverse Merger Route With SIGA
Featured Company: Human Genome Has Big Plans
The Week In Review: No ASCO Afterglow
The Day In Review: Diabetes News Rules
Dueling Diabetes Drugs Approach Market
The Day In Review: Diabetes Drug Wars
The Day In Review: Pfizer Buys Obesity Compound From Bayer
The Day In Review: Thelin and Encysive Come Roaring Back
IPO Watch: Replidyne Seeking Big Valuation
Neurocrine Sinks On Indiplon News
The Day In Review: GSK Extends Indication For Cancer Drug
The Week In Review: Biotech Recovers For A Flat Week
Europeans Endorse Stem Cells
The Day In Review: Merck Heats Up The Statin Wars
The Day In Review: Discovery Labs Seeking Alternatives
Effects Of The Bayer/Schering Takeover
The Day In Review: Sleep Drug Data From Conference
The Day In Review: Arthritis Drugs To The Forefront
Bird Flu Mutations Raise Concern
Endo/Penwest Win Oxymorphone ER Approval
The Day In Review: Pfizer Returns Indiplon to Neurocrine
The Week In Review: Zocor Heads Into The Sunset
Anadys Drug Too Potent
The Day In Review: J&J Partners With Biotech/Buys OTC Unit
The Day In Review: Genentech Stops Avastin Trial
The Day In Review: Novartis Wins Exelon OK For Parkinsons
BMS Gets OK For Cancer Drug Sprycel
The Day In Review: Biogen Idec/Elan Win European Tysabri Approval
The Day In Review: Big Approvals for Genentech and Celgene
Exelixis Is Not Genentech
The Day In Review: Big Approvals for Genentech and Celgene
The Week In Review: Upbeat End To Downbeat Quarter
The Day In Review: Q3 Starts Higher On Light Volume
The Day In Review: Sanofi In-Licenses Japanese Cancer Drug
IPO Watch: Replidyne Revisited
The Day In Review: MGI Sells Ex-US Dacogen Rights
New Hope for Stomach Cancer Survival
The Day In Review: Bayer Buys Diabetes Device Maker
The Day In Review: Bayer Buys Diabetes Device Maker
The Week In Review: Biotech Makes Gain, But
The Day In Review: Connectics Sinks On Revenue Shortfall
Valentis Collapses After PAD Drug Fails Trial
The Day In Review: Genentech Beats Estimates
Early Earnings Reports: Genentech V. Genzyme
The Day In Review: Curis/Genentech Stop Cancer Trial
The Day In Review: BMS/Gilead HIV Drug Wins Approval
An IPO May Not Be The Goal
The Day In Review: Forest Labs Wins Lexapro Reprieve
The Week In Review: Biotech Drops 3.8% To New Low
Another Conflict Of Interest At JAMA
The Day In Review: Threshold Crushed On Trial Failure
The Day In Review: Crucell, Astellas Abandon Drugs
Senate Votes To Expand Stem Cell Research
The Day In Review: Tercica and Ipsen Sign Cross-License Deal
Medicare Drug Law Brings Windfall To Pharma
The Day In Review: Gilead Pays $365 Million For Corus
Novocell Attacks Diabetes with Stem Cells
The Day In Review: Amylin Falls On Byetta Shortfall
The Week In Review: Volatility Without Change
Prana Runs Up On Publicity
The Day In Review: Shire Wins Elaprase Approval
The Day In Review: Repligen Prevails Over ImClone In Court
Another Setback For Thelin From Encysive
The Day In Review: Momenta In Generic Deal With Novartis
The Day In Review: Biotech 4.5% Higher In 3 Days
IPO Watch: Osiris Brings Stem Cells To Market
The Day In Review: Enzon Buys/Sells Drug Progams
The Day In Review: Barrier Gets FDA Nod For Xolegel
The Week In Review: Best Week Of Year For Biotech
Healthcare, GDP, Education Related To Happiness
US Remains Best Place To Invest
The Day In Review: Nuvelo Expands Achemix Deal
A Look At Humira From Abbott
The Day In Review: Pozen Inks Pain Deal With AstraZeneca
The Day In Review: Biogen Invests In ALS Compound
The Day In Review: Osiris IPO Prices Well
The Week In Review: One Solid IPO In Biotech
The Day In Review: Immunicon Rises On AstraZeneca Deal
Gurus Get Behind Big Pharma
Generic Plavix May Thin Results For Bristol/Sanofi
The Day In Review: Januvia From Merck Gets First Approval
The Day In Review: Millennium Gets Priority Review For Velcade
Genentech Signs Groundbreaking License
The Day In Review: Cephalon Gives Up On Sparlon
The Day In Review: Genzyme Seeks To Expand Synvisc Indication
Genitope And The Cancer Vaccine Struggle
The Week In Review: Biotech Gives Some Back
The Day In Review: Neurochem Climbs On Approvable Letter
The Day In Review: Shire Settles ADHD Patent Dispute With Barr
The Day In Review: Penwest And Endo Dispute Launch Costs
Roche May Have Best HDL Drug
The Day In Review: Serono Reports Positive HIV Drug Results
Bristol Seeks Injunction Against Generic Plavix
The Day In Review: Lilly Gets Approvable Letter For Arxxant
The Week In Review: Strong Gain; Stronger Breadth
Brits Reject Genentech, ImClone Drugs As Too Expensive
The Day In Review: Ranbaxy Buys Another Generic Drug Company
The Day In Review: FDA Cancels Meeting For Wyeth Psych Drug
Cell Therapeutics Pops On Old News
The Day In Review: Advanced Cell Makes Stem Cell Breakthrough
The Day In Review: GSK Signs $1.5 Billion Deal with ChemoCentryx
Stem Cell Solution Does Not Stop Controversy
The Day In Review: Advanced Cell Refinances After Stem Cell Announcement
The Week In Review: Biotech Backs Off Slightly
Zogenix Raises $60 Million, Buys Product
The Day In Review: MedImmune Pays $500 Million For Cancer Drug
The Day In Review: SGX Pharma Leukemia Drug Fails Trial
Genzyme Rebuffed In Offer For AnorMED
The Day In Review: OrthoLogic Bone Repair Drug Fails Trial
The Day In Review: Actavis Tops Barr Bid For Pliva
The Day In Review: Bristol-Myers Gets Injunction Against Generic Plavix
The Week In Review: A Late Summer Bounce For Biotech
The Day In Review: Genasense Gets Negative FDA Report
The Day In Review: EpiCept Drops On LidoPAIN Setback
Vertex And The Hepatitis C Hope
The Day In Review: Ligand Sells Avinza To King For $265 Million
The Day In Review: Ligand Sells Remaining Drugs
The Week In Review: Biotech Slips Back
Genentech Falls On Avastin Delay
The Day In Review: Genentech Casts a Pall Over Biotech
The Day In Review: Valeant Rises Despite Mixed Trial Results
Are Drug-Eluting Stents Dangerous?
The Day In Review: Bristol-Myers Squibb In-Licenses HIV Drug
The Day In Review: Biogen Idec In-Licenses PAH Drug
GlaxoSmithKline Says Avandia Helps Prevent Diabetes
The Day In Review: Synta Reports Progress Against Melanoma
The Week In Review: A Small Gain Is Still A Gain
The Day In Review: Schering-Plough Gets Approval for Noxafil
Sleep Disorders And Insomnia, Part 1
The Day In Review: ImClone Loses Erbitux Patent Fight
The Day In Review: Connetics Wins FDA Approval of Verdeso Foam
Merck Of Germany Buys Serono
The Day In Review: Big M&A Activity In Biotech
A New, Improved Version Of The FDA?
The Week In Review: Standing (Almost) Pat
The Day In Review: Merck Gets European Approval Of Gardasil
Poll: 40% Would Give Up Sex To Reach 100
The Day In Review: GPC/Pharmion Report Satraplatin Success
Sleep Disorders and Insomnia, Part II
The Day In Review: Millennium Pays $515 Million for AnorMED
A Closer Look At Remicade From Johnson & Johnson
The Day In Review: Amgen Gets Approval For Vectibix
The Day In Review: News On Multiple Sclerosis Drugs
Islet Transplants Vs. Stem Cells In Diabetes
The Day In Review: Amgen Buys Avidia For $290 Million
The Week In Review: Biotech Ends Q3 With A Bang
The Importance of Angiogenesis
The Day In Review: Gilead Gets Myogen In $2.5 Billion Deal
Great And Not-So-Great IPOs
The Day In Review: Biogen Idec Buys Another MS Drug
The Day In Review: Icahn Nixed $36/Share Offer For ImClone
Injuries A Major Source Of Death And Disability
The Day In Review: Dynavax Climbs On Journal Article
The Day In Review: Urigen Uses Valentis For Reverse Merger
The Week In Review: Moving On Up
New River Soars On ADHD Approval
The Day In Review: The FDA Gets Busy
Biomarkers Revisited
The Day In Review: Genentech Hits Its Numbers
The Other Side Of Breast Cancer Therapy
The Day In Review: Cephalon Reports Positive Results For Fentora
The Day In Review: Genentech Wins Avastin Approval For Lung Cancer
The Day In Review: J&J Sells Zantac For $509.5 Million
The Week In Review: Biotech Gains Again
Focus on Rituxan from Genentech
The Day In Review: Amgen Gets Approvable Letter
InterMune Soars On Hepatitis C Deal With Roche
The Day In Review: Rampant Deal Activity In Biotech
IPO Watch: Trubion Holds Its Range
The Day In Review: Regeneron Signs Major Deal With Bayer
The Day In Review: LaMaitre Prices IPO
Cancer Stem Cells -- Part I
The Day In Review: Gleevec From Novartis Gets 5 More Indications
The Week In Review: Biotech Goes Four For Four
Hypertension: Its Arbitrary Definition And Haphazard Diagnosis
The Day In Review: Stiefel Will Take Connetics Private
The Day In Review: Icahn Takes Over As ImClone Chairman
Disease-Specific ETFs Planned For Biotech
The Day In Review: Cambrex Sells Bio Businesses For $460 Million
Spotlight On Enbrel From Amgen And Wyeth
The Day In Review: Renovis Crushed After Cerovive Failure
The Day In Review: News From the Hepatitis Front
Cancer Stem Cells Part II
The Day In Review: Merck Buys Sirna for $1.1 Billion
The Day In Review: Biomira Buys ProlX for $25.5 Million
IPO Review Fast And Furious Action In September/October
The Day In Review: Pfizer Gets Bad News On Lipitor Replacement
A Glass Of Red Wine, An Espresso, And A Good Cigar
The Day In Review: Exelixis Cancer Drug Causes Safety Concerns
The Day In Review: VaxGen Reports Anthrax Vaccine Problems
Cancer Stem Cells Part III
The Day In Review: Abbott Buys Kos For $3.7 Billion
Herceptin From Genentech: A CloseUp
Men Would Trade Favored Possessions For More Hair
The Day In Review: OSI Gives Up On Macugen
IPO Watch: ActivBiotics Targets Bacterial Diseases/Inflammation
The Day In Review: Catalyst Prices IPO At $6
The Day In Review: ActivBiotics And Thermage Lower IPO Range
IPO Watch: Is Catalyst A Bargain At Half The Price?
The Day In Review: Genentech Pays $919 Million For Tanox
The Week In Review: Biotech Makes Gain, Despite Election
Isis Drug Produces Dramatic Cholesterol Results
The Day In Review: Mixed Results For New Merck COX-2 Drug
The Day In Review: Abbott Adds To Humira Indications
IPO Watch: Emergent BioSolutions Makes Anthrax Vaccine
The Day In Review: Pfizer Buys Embrex For $155 Million
Epogen From Amgen Attacked
The Day In Review: Pharmion Pays $104 Million For Cabrellis
The Day In Review: Another Indication For Herceptin From Genentech
The Week In Review: Recent IPO Vanda Leads Biotech Higher
CoTherix Takes $420 Million Buyout From Actelion
The Day In Review: Somaxon Reports Success For Sedative Silenor
Fatalities And Injuries From Falls On The Rise
The Day In Review: Pfizer And Teva Settle Generic Drug Lawsuits
The Day In Review: Roche And PDL Go Their Separate Ways
The Day In Review: Quiet Session After Thanksgiving Holiday
The Week In Review: Biotech Takes A Small Breather
The Quest to Look Younger Fuels an Injectable Boom
The Day In Review: Targeted Genetics Soars While Biotech Falls
Featured Company: BioCryst Is More Than A Flu Company
The Day In Review: Artes Medical Sets IPO Terms
The Day In Review: Dyanavax Reports Heplisav Success Against Hepatitis B
The Day In Review: Deals Dominate The News
The Day In Review: Pfizer To Spend $100 Million At Scripps
IPO Watch: Affymax Aims At Anemia Market
The Week In Review: Biotech Lower; Awaits Pfizer Monday
The Day In Review: Pfizer Takes 10% Shellacking
The Day In Review: More Success For Acomplia From Sanofi-Aventis
IPO Watch: Artes Offers New Wrinkle For Skin Rejuvenation
The Day In Review: Halozyme Strikes $600 Million Deal With Roche
Study Finds Taste Modulated By Central Neurotransmitters
The Day In Review: Vanda Soars On Iloperidone Success
Pharma: Diversification Or Pure Play?
The Day In Review: GSK Buys Domantis For $454 Million
The Week In Review: Big Jumps For Vanda And Reneuron
Daily Aspirin May Prevent Or Delay Prostate Problems
The Day In Review: Two Drug Failures Plus ASH Announcements
The Day In Review: Deals Dominate Biotech News
The Day In Review: Vertex Announces Positive Hepatitis C News
The Day In Review: Forest Labs Buys Cerexa For $480 Million
China Biotech: Bridge Pharma Cuts Drug Development Costs
The Day In Review: Affymax Stages Strong IPO
The Week In Review: Hope In The Biotech IPO Sector
The Day In Review: BioSante Rises On FDA Approval
A Look At Progressive Multi-Focal Leukoencephalopathy
The Day In Review: Glaxo Pays Record For Genmab Cancer Drug
The Day In Review: Genentech Buys Pipeline From Altus
GlaxoSmithKline Buys Praecis For $55 Million
The Day In Review: Lilly Stops Brain Cancer Trial
The Day In Review: SciClone Soars On Positive Melanoma Results
The Week In Review: Biotech Fading At The Finish Line
The Day In Review: Telik Slumps On Negative Telcyta Trial Data
Featured Company: Geron, Stem Cells, and Telomerase
The Day In Review: Targacept Climbs On AstraZeneca Payment
The Day In Review: Threshold Reports Success Against Pancreatic Cancer
The Day In Review: Oscient Works Better Deal For Factive
The Week In Review: Flat Week Ends Flat Year
2006 Was A Year For Reagents And Tools
Will Biotech IPOs Bounce Back in 2007?
The Day In Review: Two Big Deals To Start The New Year
Study Examines Time Cost Of Cancer Therapy
The Day In Review: BioCryst Gets Flu Drug Support
The Day In Review: Controversy For Genentech Cancer Drug Pertuzumab
The Week In Review: How To Start The Year Off Right
The Day In Review: Seattle Genetics Sells Cancer Drug To Genentech
Day One At The JPMorgan HealthCare Conference
The Day In Review: Genentech Adds to Pipeline, Again
The Day In Review: Genentech Handily Beats Estimates
Day Two At The JP Morgan HealthCare Conference
Day Three At The JPMorgan HealthCare Conference
The Day In Review: Bristol-Myers Squibb In $1.2 Billion Pact With AstraZeneca
The Final Day Of The JPMorgan HealthCare Conference
The Day In Review: Genentech Inks Third Deal This Week
The Week in Review: A Good Start in 2006 For Biotech
JPMorgan Conference Wrap
The Day In Review: BioCryst Begins Pivotal Trial of Fodosine
Forest Labs Beats The Street
The Day In Review: Gemzar From Lilly Effective In Pancreatic Cancer
Provenge From Dendreon Still Problematic
The Day In Review: Adherex Buys Out GSK Option On Eniluracil
The Day In Review: Abbott Sells Lab Division To GE For $8 Billion
The Week In Review: Biotech Rises To New Record
IPO Watch: Oculus Seeks Niche In Wound Healing
The Day In Review: Amgen Rises On Speculation Over Patent Suit
The Day In Review: Coley Drops After Ending Hepatitis C Program
The Day In Review: Renovis Cuts Staff By 40%
IPO Watch: Chinese Biotech 3SBio Files For American IPO
The Day In Review: Amgen Disappoints After The Bell
Amgen Takes Hit On Worries
The Day In Review: Amgen Drags Biotech Lower
The Week In Review: Genentech, Amgen Take A Toll On Biotech
Amgen and Genentech Hit by Blockbuster Effect
The Day In Review: Will Sanofi-Aventis Merge With Bristol-Myers Squibb?
Beijing Med-Pharm Beefs Up Its Chinese Distribution Network
The Day In Review: Alfacell Receives Orphan Drug Status For Onconase
China Generates New Opportunities for Biomedical Companies
The Day In Review: AstraZeneca Enters Two Partnerships Worth $800 Million
Modeling A Flu Pandemic
The Day In Review: AstraZeneca Buys Arrow Therapeutics; Cuts Workforce
IPO Watch: Molecular Insight Seeks Imaging and Radiotherapeutic Drugs
The Day In Review: Big Pharma Merger In Japan
The Week In Review: Biotech Treks Higher
China Biotech Gets Major Boost
The Day In Review: Wyeth And AstraZeneca Sign More Deals
The Day In Review: ImClone Chooses To Go It Alone
Agendia's MammaPrint Gets FDA Approval
The Day In Review: IPO Sector Heats Up
Restless Glaxo And The Making Of A Blockbuster Drug
The Day In Review: Accuray Has Spectacular IPO
IPO Watch: Optimer Drops Price, Then Trades Well
The Day In Review: Sanofi Loses Lovenox Patent
The Week In Review: Big Week For IPOs
Onyx Doubles On Positive Nexavar News
The Day In Review: Another Setback For Acomplia From Sanofi-Aventis
The Day In Review: Merger Monday
US And UK At Bottom Of The List For Child Well-Being
The Day In Review: Osiris Stem Cells Treatment Has Unexpected Results
The Day In Review: FluMist from MedImmune Outperforms Injected Vaccine
Will Bayer Buy Onyx?
The Day In Review: Biotech Drops 20 Points; Up 4 Points On Week
The Week In Review: Onyx Is The Star For The Week
The Day In Review: Shire Buys New River For $2.6 Billion
The Day In Review: Genentech Loses Cabilly Patent Ruling
Genentech Takes Hit On Avastin Success
The Day In Review: Allergan Expands Obesity Franchise
The Day In Review: Genentech Extends Uses For Avastin And Xeloda
Hedge Fund Seeks Sale of Acorda
The Week In Review: Biotech Holds Steady
Hold The Deodorant And The Aftershave
Biotechs On Best And Worst Lists In WSJ Review
The Day In Review: New River/Shire Win Approval For ADHD Drug
The Latest Extreme Sport: X-treme Eating
The Day In Review: Biotech Takes A 3% Hit
The Day In Review: Xoma Signs $230 Million Partnership With Takeda
IPO Watch: Rosetta Genomics And MicroRNAs
The Day In Review: Amgen Hit With SEC Investigation
The TriMedicine Conference In San Francisco
The Day In Review: Hopeful Results From HIV Conference
The Week In Review: Rough Week For Biotech
The Day In Review: Lilly Buys Insomnia-Focused Hypnion
The Day In Review: Novartis Gets Approval For Hypertensive Drug Tekturna
The Day In Review: Avalon Signs $200 Million Deal With Merck
The Day In Review: Hollis-Eden Loses Stockpile Contract For Neumune
The Day In Review: Amgen Must Post Black Box Warning
IPO Watch: Tongjitang Chinese Medications
The Week In Review: Flat Looks Good
The Day In Review: Schering-Plough Buys Organon For $14.4 Billion
The Day In Review: Glaxo Gets Approval For Tykerb
More Mumbo-Jumbo of Cancer Results
Aradigm: A Speculative Value Play
The Day In Review: Critical Therapeutics Climbs On Co-Promotion Deal
Potential Trouble Ahead For Big Biotechs
The Day In Review: NPS Cuts Staff Again
California Awards $74.5 Million For Stem Cell Research
The Day In Review: Adams Respiratory Guides Lower
The Week In Review: Biotech Slides Slightly Lower
Acadia Doubles On Schizophrenia Drug Data
The Day In Review: AtheroGenics Tumbles On Drug Test Failure
The Day In Review: InterMune Retrenches
Tamiflu From Roche Under Cloud In Japan
The Day In Review: BioSimilar Drug Enters Trial
XShares Will Offer Asian Biotech ETF
The Day In Review: Eisai Buys Morphotek For $325 Million
Bad News From Amgen And Genentech
The Day In Review: A Perfect Storm for Genentech And Amgen
The Week In Review: Biotech Recovers Some Lost Ground
The Day In Review: Biosite Takes $85 Offer From Beckman Coulter
The Never Ending Saga Of Bypasses And Stents
The Day In Review: Regeneron Up On AMD Data
Aradigm Revisited: A Speculative Value Play
The Day In Review: Sanofi-Aventis Lands Cancer Vaccine For $680 Million
The Day In Review: CuraGen Gets $155 Million For Gene Sequence Division
Provegne From Dendreon Recommended By FDA Committee
The Day In Review: Novartis Pulls Zelnorm Off The Market
The Week In Review: Barron's Touts Alzheimers Drugs From Wyeth
The Day In Review: Roche Picks Up Antibody Firm For $56.5 Million
Stem Cell Patents Revoked
The Day In Review: Cell Genesys Climbs On GVAX Results
The Day In Review: Roche Buys BioVeris For $600 Million
The Day In Review: Bidding War Erupts For Biosite
The Week In Review: Biotech In Positive Territory For 2007
The Day In Review: Agilent Buys Stratagene For $245.5 Million
The Day In Review: Entereg from GSK and Adolor Fails Test
The Day In Review: Genentech Beats Estimates Slightly
The Day In Review: MedImmune Puts Itself Up For Sale
Third Point Increases Heat On CEO of PDL BioPharma
The Day In Review: Dyax Jumps On Positive Data
Contact Us
Advanced Search
Week in Review
The Week in Review: China Steps Up Narcotics Monitoring
The Week in Review: US Pharmacopeia Opens Facility in Shanghai
The Week in Review: US Companies Increase Presence in China
The Week In Review: Drug/Food Safety Still in the News
The Week in Review: TCM Goes Mainstream
The Week In Review: China Strategy Evolves for AstraZeneca
The Week in Review: China Withdraws Leukemia Drug
The Week in Review: Safety News Dominates
The Week in Review: TCM Drug Investigated as Neuroprotector
The Week in Review: China Laughs Last
The Week in Review: WuXi PharmaTech Estimates Q2 Results
The Week in Review: Valuation of WuXi PharmaTech
The Week in Review: Covance Advances on its Shanghai Lab
The Week in Review: Benda Qualifies for Nasdaq Listing
The Week in Review: China and Clinical Trials
The Week in Review: Anesiva Forms JV with Fosun Pharma
The Week in Review: Consolidation in China Biotech
The Week in Review: Large IPO Announced
The Week in Review: The Evolution of China Biopharma
The Week in Review: Regenerx Wins China Patent
The Week in Review: Good Week for China BioPharma Investment
The Week in Review: China Biopharma Investing, Continued
The Week in Review: Progress in China BioPharma
The Week in Review: Cross Border Pharma Activity
The Week in Review: What’s Happening with China Biopharma Investing?
The Week in Review: Safety Regulation Improves; Drug Business Expands
The Week in Review: East-West Pharma Interaction
The Week in Review: East-West Interdependence in 2007 China Biotech
The Week in Review: 2007 a Good Year for US-listed China Life Science Companies
The Week in Review: Big Themes and Real Progress
The Week in Review: China Speed
The Week in Review: China Biopharma Investing
The Week in Review: Looking Good for 2008 China Biopharma Investing
The Week in Review: CROs in the News
The Week in Review: The Virtualization of Biopharma
The Week in Review: New China Biopharma Investments
The Week in Review: Deals and Drugs in China Biopharma
The Week in Review: SFDA To Become Part of Ministry of Health
The Week in Review: Earnings and More in China Biotech
The Week in Review: China Biotech Approvals, Deals and Company News
The Week in Review: Consolidation and Growth in China Biotech
The Week in Review: China Biotech Stocks Down; Activity Up
The Week in Review: Deals and More in China Biotech
The Week in Review: Consolidation in China Life Science Companies
The Week in Review: Investments in China Drug Development
The Week in Review: Investment Capital for China Biopharma
The Week in Review: What’s Not to Like in China Biopharma?
The Week in Review: The Metrics of Growth in China Biopharma
The Week in Review: The China Biopharma Beat
The Week in Review: Earnings, Deals and Drug Development in China
The Week in Review: Broad Trends, Individual Companies in China Bio
The Week in Review: Deals and Drugs in China Bio
The Week in Review: BIO Convention and More
The Week in Review: A Week of Collaborations in China
The Week in Review: China Biomedical Evolving
Week in Review: ChinaBio® Hosts Successful Investor Forum
The Week in Review: China Biomedical Investment
The Week in Review: Summer Slump for News
The Week in Review: Company Profiles and Drug Advancement
The Week in Review: Earnings and More in China Biopharma
The Week in Review: Earnings, Earnings, Earnings
The Week in Review: Earnings and Development
The Week in Review: An FDA Office in China and Deals/Financings
The Week in Review: Trials and Deals in China Biopharma
The Week in Review: Broad Views, Individual Company Details
The Week in Review: A Big Question
The Week in Review: Deals, Development and Financials
The Week in Review: Deals, Earnings and a Profile of LEAD Therapeutics
The Week in Review: Economic Troubles
The Week in Review: The FDA, China Deals and Earnings
The Week in Review: Broad Themes and Deals
The Week in Review: October is Finally Over
The Week in Review: More Fallout from Economic Crisis
The Week in Review: Earnings Week
The Week in Review: Biopharma News Back in the Forefront
The Week in Review: China Deals and Healthcare Stimulus
The Week in Review: New AIDS Vaccine Leads China Biopharma News
The Week in Review: Innovation in China Biopharma
The Week in Review: China Biopharma Thrives Despite the Economy
The Week in Review: No Vacation for China Biopharma News
The Week in Review: Systemic Changes in China Biopharma
The Week in Review: Cautious Optimism
The Week in Review: Innovative Structures for Biopharma Deals
The Week in Review: China Biopharma Investment
The Week in Review: Prestigious Pfizer Award Goes to HD Biosciences
The Week in Review: The Art of the Almost-Deal
The Week in Review: Cross Border Collaborations
The Week in Review: Partnerships and Financials
The Week in Review: Innovative China Life Science Displayed in Hong Kong
The Week in Review: Investments, Partnerships, Deals, and Earnings
The Week in Review: China Releases Official Health Reform Plans
The Week in Review: Deals Dominate
The Week in Review: Biopharma News from a Holiday Week
The Week in Review: A Second Major Deal for China Biopharma in 2009
The Week in Review: January Off to a Slow Start
The Week in Review: Looking Forward, Looking Back
The Week in Review: China Life Science, Developing
The Week in Review: Deals and Investments in China Life Science
The Week in Review: Invention and Design
The Week in Review: Earnings Week
The Week in Review: Deals and Earnings
The Week in Review: A New Phase?
The Week in Review: Moving Forward
The Week in Review: New Developments
The Week in Review: Doing Deals
The Week in Review: Transactions and More
The Week in Review: Marking Progress
The Week in Review: SFDA’s Green Channel Allows Speeded-up Approval
The Week in Review: Pfizer Builds China Relationships
The Week in Review: A New Cross-Border Clinical Trial
The Week in Review: The Business of China Life Science
The Week in Review: TCMs, Clinical Trials and Approvals
The Week in Review: US Clinical Trial of China Diabetes Drug
The Week in Review: Flu’s News
The Week in Review: Deals and Products
The Week in Review: Partnership Panels from ChinaBio® Day
The Week in Review: Three Life Science Companies to IPO on GEM
The Week in Review: IPOs, Patents, Investment Funds and More
The Week in Review: Cross-Border Deals
The Week in Review: Deals and Collaborations
The Week in Review: International Initiatives
The Week in Review: Is CRO Consolidation a New Theme?
The Week in Review: Major Investments
The Week in Review: The Bull in China’s R&D Shop
The Week in Review: CROs Consolidating
The Week in Review: Two More R&D Centers; One PE Fund; One IPO
The Week in Review: ChinaBio® Investor Forum Held in Tianjin
The Week in Review: Deals and CRO News
The Week in Review: Medical Device and Big Pharma Milestones
The Week in Review: Holiday Transactions and Awards
The Week in Review: Year-End IPO Review
The Week in Review: New Investments for a New Year
The Week in Review: China Life Science Convergence
The Week in Review: China Pharma Investment, Company Progress
The Week in Review: Suzhou Nanomed Funded by Softbank
The Week in Review: New Investments in China Life Science
The Week in Review: 3SBio and Ascentage Form Cancer Partnership
The Week in Review: China New Year’s News
The Week in Review: New Deals in China Life Science
The Week in Review: China Life Science to Grow 22% Per Year Through 2013
The Week in Review: AutekBio Raises $100 Million for Biologic CMO
The Week in Review: China Offers Lion's Share of Emerging Market Growth
Stock Watch
WuXi Reports 99% Increase in Q2 Revenue
Four Shanghai CROs To Go Public
Simcere and Tongjitang Attractively Priced
IPO Watch: Tongjitang Chinese Medicines Prices at $10
Nasdaq To Start Chinese Stock Index
IPO Watch: Simcere Supplies High-End Generics In China
IPO Watch: WuXi PharmaTech Next?
A Listing of Publicly Held Chinese Life Science Companies
IPO Watch: WuXi PharmaTech Expected to Stage US IPO
IPO Watch: WuXi PharmaTech Files For NYSE IPO
Simcere Posts Higher Revenues, Earnings for Q2
Mindray Medical Beats Street
WuXi Prices IPO above Range
3SBio Hits its Q2 Targets
American Oriental Makes Another Acquisition
Sinobiomed Buys Distributor
Tongjitang Chinese Medicines Reports Higher Q2
Bayer/Onyx Report Success in Asian Trial for Nexavar
Aspreva Pays Roche for CellCept Development in China
Optimer Pharma to Talk Collaboration with C&O
China Shenghuo Announces Higher Q2 Results
Lilly Partners with Chi-Med
Sinovac Profitable in First Half
China Biopharma Struggling with Enshi Acquisition
3SBio Soars 23% on Analyst Comment
Shares of China Pharma of Hainan on a Roll
Simcere Reports In-Line Q3; Takes Haircut
Tongjitang Key Drug Flat in Q3
China Nepstar Prices IPO at 30% Premium to Range
3SBio Rises after Reporting Q3 Results
Insiders Sell Benda Shares despite Positive India News
Jiaying Pharma to IPO in Shenzhen
ShanghaiBio Plans US IPO in 2008
The China IPO Window is Open for Pharma Companies
Anhui Anke Biotech Nearly Triples in ChiNext’s First Day
Mixed Results for China Life Science US IPOs
China-listed Life Science IPOs Are Hot
Mindray Medical Will Beat Analysts’ 2009 Predictions
Sinovac Issues 2009 Guidance; Announces Secondary Stock Issue
Sinovac Prices Secondary Offering
Legal & IP Issues
Introgen Hints at Suit Against Benda/SiBiono
Novartis Jilts India on Investment
Big Pharma Chooses China over India
Sinobiomed Granted Patent in China
Waves of Changes in Chinese Patent Law and Regulations -- Part I
Waves of Changes in Chinese Patent Law and Regulations – Part III
Waves of Changes in Chinese Patent Law and Regulations – Part II
Waves of Changes in Chinese Patent Law and Regulations–Part IV
Waves of Changes in Chinese Patent Law and Regulations: An Update, Part I
Waves of Changes in Chinese Patent Law and Regulations: A Further Update, Part I
Waves of Changes in Chinese Patent Law and Regulations: A Further Update Part II
Waves of Changes in Chinese Patent Law and Regulations: A Further Update--Part III
China Will Lead Patent Filings in 2012
Waves of Changes in Chinese Patent Law and Regulations: Final Update, Part I
Waves of Changes in Chinese Patent Law and Regulations: Final Update -- Part II
Waves of Changes in Chinese Patent Law and Regulations: Final Update – Part III
New Patent Rules Take Effect on October 1
Novartis Says Weak IP Protection Makes India R&D Impossible
Allele Granted Broad RNAi Patents in China
Gov't & Regulatory
China Gets Serious about Drug and Food Safety
China Executes ex-SFDA Head
Transparency is Goal for Chinese FDA
China Puts Money Behind Safety Pledge
China Starts Special War for Safety
China to Allow Investment in Hong Kong Stocks
China Rejects St. Jude Pacemakers
Restrictions Lifted on Aida’s Antibiotic
China Fine Tunes its VC/PE Rules
Multinational Pharma Wants More from China’s Drug Rules
China Submits Medical Reform Plan
China to Commit 11 Billion RMB ($1.5 Billion) to Drug Innovation
SFDA Becomes Part of Ministry of Health Again
China’s SFDA to Shorten IND Wait for Innovative Drugs
China Sky One Granted Five Approvals
Drug Deaths Prompt More Efficient SFDA Response
FDA to Open Three China Offices This Year
US and China to Explore TCM Together
Waves of Changes in Chinese Patent Law and Regulations: An Update, Part II
FDA to Open China Office in October
Experts Discuss FDA Inspections in China
China Proposes Universal Health Insurance
Final China Medical Reform Plan Expected In January
China Will Experiment with Zero Markup on Drugs in Hospitals
China Will Spend $123 Billion on Healthcare Reform
China Unveils 11-Year Health Plan
China Reveals 2009 Medical Reform Plans
China Releases a New National Drug Reimbursement List
China’s State Council Reveals Hospital Reform Plan
China Allocates $5.5 billion to Implement Healthcare Reform
Deals & Financings
Tongjitang Acquires Fellow TCM Company
Drug Distributor Jointown Receives Overseas Capital
China Is Hot: Venture Capital, Halter Index Soar
Beijing Med-Pharm Extends Chinese Distribution Network
J&J Buys Chinese Cosmetics Company For $300 Million
Shanghai Century Buys Sichuan Kelun
Chi-Med Rumoured Close to Signing Major Deal
Amarillo Biosciences Signs Deal with CytoPharma of Taiwan
Charles River Labs Enters China
Lilly Contributes $10 Million to BioVeda China VC Fund
PharmEng Makes China Acquisition
Two Shanghai CROs Join Forces
Chemizon Announces Reverse Merger with South Korean Company
China Biopharma Will Buy Chinese Drug Distributor
American Oriental Pays $30 Million to Acquire Rival
Legend Holdings Expected to Win Bidding for Shijiazhuang Pharma
China Shenghuo Doubles after its IPO
Shijiazhuang Pharma Bought by Legend, Goldman Sachs
Benda Adds to Ownership of Cancer Gene Therapy Drug
China Biopharma Strikes Deal for Antiviral
DSM Forms Joint Venture with North China
China Biopharma Will Bring Staph Vaccine to China
Beijing Double-Crane Offers New Shares
NovaMed Pharma Books $5 Million in Venture Capital
China Resources (Holdings) Consolidating China Pharma
Simcere Takes Majority Stake in Rival Boda
Beijing Med-Pharm Buys Remaining 51% of Sunstone
Laiyang Jiangbo Pharma to Execute Reverse Merger
Ranbaxy Seeks China Joint Venture
AMDL Signs Distribution Deal
China Nepstar Pharmacy Chain Files for IPO
Beijing Med-Pharm Signs Another Distribution Deal
Private Equity Firm Invests in CRO ChemPartner
Sunway and Genzyme to Collaborate on Gene Therapy
Benda Forms JV for HIV Vaccine
An IPO for ShangPharma?
LEAD Lands $17 Million to Launch US-China Pharma
Q2 Investment Activity in China: The Numbers
Newly-Formed Genesis Pharma Buys Patent on Anti-clotting Drug
Case Study: Cross-border Investing Works for Life Science Angels
Dragon Pharma Sells EPO Unit
Simcere Makes Cancer Acquisition; Misses on Revenue
China Medical Buys Company to Add ECLIA Testing Products
Yunnan Baiyao Acquires Two Small Pharmas
WuXi PharmaTech Makes US Acquisition
Unigene Sets Up China Biotech JV with Shijiazhuang Pharma
Biosensors Buys China Stent Maker
Chengdu Tianyin Pharma Completes Reverse Merger
Sundia MediTech Rides WuXi IPO to Series B Funding
US Venture Capital Investing in China Hits Record in 2007
Shenzhen Chipscreen Received $28 Million for Cancer Drug
NovaMed Raises $14 Million to In-license New Molecules
Sinovac Closes $9.8 Million Follow-on Offering
Private Equity Fund Raising for China Up 151% in 2007
Baxter Pays $24 Million To Bring JV In-house
bioMérieux to Move Immunoassay Production to New Shanghai JV
China Sky One Medical Raises $25 Million
AsiaPharm Accepts Private Equity Offer
Mylan Unit Ups Stake in China Subsidiary
Chemizon Collaborates with Korean Research Institute
Beijing Med-Pharm Completes Sunstone Acquisition
Shanghai Century Acquisition Nixes Kelun Pharma Purchase
RHEI Licenses China Rights to ADHA Nutraceutical
Lotus Private Placement Includes Make Good Clause
Time Runs Out on Bayer-Topsun Deal
China Sky One Makes $8.3 Million Acquisition
Valeant Sells Pan-Asia Marketing Rights to Invida
Hovione Buys Stake in Zhejiang Hisyn
More Time for Bayer-Topsun Deal
CEO Bids to Take Tongjitang Private
China Aoxing To Acquire TCM Pain Drug Company
Institutions To Block AsiaPharm Private Equity Deal
Medigen In-licenses Asian Rights for Cancer Drug
Tongjitang Buys TCM Company with Respiratory Drug
Amarillo Biosciences Signs Deal with CytoPharm of Taiwan
Morgan Stanley to Evaluate Buyout Offer for Tongjitang
Aida Pharma Acquires Jiangsu Institute
ProGenTech Closes $21 Million Financing
Commonwealth and Venturepharm Form CRO JV
CROs Chemizon and Crown Bioscience Partner Up
WuXi Announces 10 Million Share Secondary Offering
Actavis Buys Controlling Interest in China API Maker
China YTC Will Merge Subsidiary with Supplier
SciGen Buys China Rights to Generex Oral Insulin Spray
Alliance Established between China and India CROs
AsiaPharm Signs Deals with Two Scottish Pharmas
American Oriental Buys Stake in China Aoxing
Bio-Bridge Sciences Forms China JV with JR Scientific
Bionet Enters China Alliance with Vita Genomics
Simcere Buys Cancer Drug Company
Unigene Breaks Ground for China JV Facility
US Scientist Forms Changzhou Vaccine Company
VC Investments in China Biotech/Healthcare Climb in Q1
Frontage Labs Receives $10 Million for China Expansion
Bio-Bridge Buys Majority Interest in China Company
WuXi PharmaTech Postpones Secondary Offering
Details Added to Venturepharm Asia JV Plan
45% Stake in Shanghai Schering-Plough JV For Sale
3SBio to Commercialize Iron Deficiency Agent in China
Kiwa Bio-Tech JV Will Develop Veterinary Anti-Viral Spray
China Pharma Raises $10 Million in Secondary Offering
InSite Visions Signs Essex to Market AzaSite® in China
American Oriental To Repurchase $75 Million of Stock
NewBiomed Licenses Vaccine Adjuvant to Walvax
Access Pharma Ties China Clinical Trials to Drug Out-licensing
Genesis Accepts Strict Terms for $30 Million Financing
WuXi PharmaTech and AstraZeneca Sign New Three-Year Collaboration
Daiichi Sankyo to Acquire Control of Ranbaxy
China Sky One Makes $7 Million Acquisition
Alpharma Forms Vancomycin JV with Zhejiang Hisun
Cordium Links Launches Cardiac Safety JV in China
Immtech to Start CRO with Beijing Capital Medical University
Oculus to Use Bayer for Approval of Microcyn in Animals
BioAlliance SA Out-licenses Loramyc in China to NovaMed Pharma
Microbix to Build Flu Vaccine Plant in Hunan
WuXi PharmaTech and Covance Will Partner in JV
Krka Makes Small Investment in Two China Pharmas
Yunnan Baiyao to Take Lijang Medicine In-house
Pacific Biopharma: Two Parts US; One Part China
NovaMed Will Market Six Cancer Drugs in China for Pfizer
Tongjitang Tanks after Buyout Offer Withdrawn
Biofield in $365 Million China Breast Cancer Diagnostic JV
Bayer Finally Closes Topsun Acquisition
American Oriental to Offer $85 Million in Notes
Bio-Bridge Raises $2.8 Million for Vaccine Development
AMDL Acquires Drug Distributor
American Oriental Prices Convertible Notes
Commonwealth Bio Raises $1 Million for Venturepharm JV
CRO Tigermed Raises $5 Million in VC from Qiming
Shanghai Offers Financing to Early-stage Biotechs
Management Key in Attracting Venture Capital in China
China VC Hits Record Level in Q2
CRO Consolidation: Indian Firm Veeda Buys US CRO
CRO Tigermed Closes $5 Million Series A Funding
VCs Turning Their Noses Up at Chinese CMOs
Consortium Formed for Early Stage Biotech Investment
BMP Sunstone Acquires Pediatric Drug Company
GNI In-licenses Hepatitis Drug from EpiCept
GSK Makes Generics Deal to Penetrate Emerging Markets
Genelabs to Collaborate on HCV Drug in Taiwan
NovaMed to Distribute Epilepsy Drug for Sanofi-Aventis
Lotus Unveils Plans for New Manufacturing Facility
Zhejiang Huahai To Provide Finished Drug Product to Merck
Sinobiomed Takes in New Capital
Vaccine Maker JGAD Completes Reverse Merger with China Bio-Immunity
HD Biosciences Funded by Lilly, Pfizer and Morningside
China Medical to Float $150 Million Note Offering
American Oriental Reveals Huge Acquisition in Q2 Report
Schering-Plough Takes Sole Possession of its China JV
Venturepharm Invests in US CRO and Details Building Plans
More Deals for Venturepharm
Beijing Beilu Pharma Raises 67 Million RMB
Biomics Biotech Closes 34 Million RMB B Round
Will Sinopharm and CITIC IPO?
China Botanic Buys Guangdong Kangli Pharma
Dermatology Company Profex Announces $15.5 Million Series A
US Stem Cell Banking Company Receives Investment from Asia
Huifeng to Assume Control of Medical Device Maker
Qiagen to Help Develop China Food Diagnostic Tests
WuXi PharmaTech and Covance Nix Partnership
China Biologic to Buy Controlling Interest in Competitor
Three Rivers Buys China Rights to Infergen
Huifeng Firms Up Deal to Control Xi’an Qinba
China Medical Acquires HPV Diagnostic Test for $345 Million
ProGenTech Aims Entura Machine toward Diagnostic Market
InforSense to Market Pharsight’s Products in China
Pioneer to Distribute Spinal Products in China through Bonovo
China Biologic Acquires Another Plasma-based Pharma
Fosun Buys 5% Stake in Tongjitang Chinese Medicines
American Oriental Announces Two Acquisitions; Terminates a Third
China Sky One Inks Distribution Deal for Asthma Patch
Diagnostics Company Chemclin Closes $16.5 Million Series B
China Medical Wrestles with Accounting for $345 Million Acquisition
China Sky One Buys Breast Lesion Drug
NeoStem Announces Two China M&A Transactions
TomoTherapy Buys China Linear Accelerator Company
WuXi PharmaTech Inks New Three-year Deal with Pfizer
China Sky One Pays $2.2 Million for Nine New Drugs
Chiral Quest Closes $13 Million Series B
2008 China Biopharma M&A Deals Running Ahead of 2007
BMP Sunstone Buys Unique Constipation Drug
GSK Signs Pre-JV Vaccine Pact with Shenzhen Neptunus Interlong
Tigermed Extends CRO Network to Russia and Korea
Lilly Adds New Target to Hutchison Meditech Collaboration
AnaSpec Signs Distribution Deal with Shanghai Universal Biotech
Smiths Group Buys China Device Maker
Tigermed Builds Up Phase I CRO Services
Erye Pharma Invests in NeoStem
China Medical Sells HIFU Business to Chairman/CEO
BMP Sunstone Bumps Non-GAAP Net Income Higher
China Biologic Accepts Smaller Stake in Qianfeng Acquisition
ProGenTech to Develop Diagnostics with China’s CDC
New VC Fund to Back Biopharmas in Jilin Province
BMP Sunstone Acquires 50% Stake in Pediatric Drug Maker
Medtronic Buys 15% of Shandong Wiegao; Opens JV
Tiantan Biological to Acquire Rongsheng Pharma
Shinva and GE Healthcare Form Medical Device JV
China Medical Defends HIFU Subsidiary Sale
Forma Therapeutics, with Significant China Connection, Raises $25 Million
S*Bio Signs $550 Million Deal with Onyx
Shares of American Oriental Slide after Real Estate Purchase
Hutchison MediPharma Options Program to J&J
S*Bio Licenses Early-Stage Cancer Drug to Tragara
SinoGenoMax to Offer Cogenics’ Genotyping Services in China
NovaMed Buys China Rights for Cancer Pain Drug from Orexo
Genesis Pharma Buys TCM Manufacturer for $12.2 Million
RHEI Pharma Options China Rights for Invisicare
Roche Innovates with Deal Making in China
OriGene Pays $6.5 Million for Shenzhen P&A Biotech
Lotus Purchases Ulcer Drug for $7.9 Million
Is Pharmacyclics Looking towards China?
Frontage Labs Expands Relationship with Beijing Pharma
China Sky One Out-Licenses Distribution of Prostate Drug
Beijing SL Pharmaceutical to Form In-Vitro Diagnostic JV
CRO Tigermed Strikes Deal with Biostatistician MacroStat
Immtech Signs MOU with Beijing Pharmaceutical Group
Lee’s Pharma Acquires Oral Antibacterial Drug from Nippon Shinyaku
Simcere and Epitomics Form mAb Development Partnership
Nanjing Chuanbo Biotech to Set Up JV in Britain
CRO BioDuro Signs Collaboration with AstraZeneca in Beijing
Royal DSM Forms JVs with North China Pharmaceutical Group
Bayer and Bioton Discussing Insulin Distribution Deal for China
Tongjitang Chinese Medicines Makes Another Small Acquisition
Sinobiopharma Seeking US Partner for Lead Drug
ReSearch Pharmaceutical Buys China CRO Paramax
BioDuro Expands Discovery Collaboration with Roche
NeoStem Raises $11 Million from Asian Investors
China Biologic Closes Qianfeng Acquisition
Shanghai ChemPartner Forms Alliance with Japan Pharma
Pacgen Acquires XPhase, Which Owns Rights to China Anti-Anxiety Drug
BioVeda May Set Up Guangzhou Life Science Fund
NeoStem Licenses Stem Cell Wound Healing Product
NeoStem Acquires Asia Rights to Stem Cell Treatment
China Aoxing Buys Novel Menstrual Pain Drug
Kleiner Perkins Invests $15 Million in CRO Jinsite
China Sky One Signs Cancer Drug Agreement with Taiwan Company
Hamner Institute Builds Biopharma Bridge with China Medical City
Simcere Buys Stake in Vaccine Company
China Biologic Raises $9.6 Million
GSK and Shenzhen Neptunus Create Flu Vaccine JV
Commonwealth Biotechnologies Acquires China Peptide Producer
Bio-Bridge Science Begins China JV
NeoStem Signs China Stem Cell Deal with Enhance BioMedical
NeoStem Raises an Additional $4 Million
Novast Receives $25 Million in Series C Round
Two China Pharma-Related Companies IPO – Guilin Sanjin and Chemspec
Bayer Schering to Distribute Bioton's Insulin
Sinopharm Expected to Raise 7 Billion RMB in Hong Kong IPO
Benitec and Biomics to Collaborate on RNAi Treatment for Hepatitis B
GSK to Distribute Dr. Reddy’s Generic Drugs in Developing Markets
SciClone Buys China Rights to Anti-Nausea Drug
aTyr Pharma of San Diego and Hong Kong Raises $12 Million
Pfizer Underwrites Basic Research at Shanghai Institutes
China Aoxing Sells Shares for $5 Million
Cheezheng Tibetan Medicine to IPO on Shenzhen Exchange
Shenzhen Mellow Hope to Market NCPC Hepatitis B Vaccine Internationally
S-Evans Biosciences Obtains China Rights for Stem Cell Technology
Sinopharm Signs Up Big Investors for Hong Kong IPO
PerkinElmer Pays $64 Million for China Diagnostic Company
Cleveland BioLabs Licenses Cancer Drug to Zhejiang Hisun
Asia Pharmaceutical Books $10 Million VC Investment from Silicon Paradise
Hualan Biological Signs Middle East Flu Vaccine Deal
Three Life Science Companies to IPO on New GEM Exchange
Zhangjiang Hi-Tech Park Buys Stake in Buchang Pharma
CCB Opens RMB Private Equity Fund for Healthcare
GSK Forms Vaccine JV with Jiangsu Walvax
Inviragen and SingVax Merge; Raise $15 Million
NeoStem Moves Forward on China Biopharma Acquisition
Starr Invests $20.5 Million in Techpool
China Pediatric Completes Reverse Merger
Breaking News: California’s $3 Billion Stem Cell Fund Signs MOU with China
Simcere to Develop Cancer Drug from OSI Pharma in China
Sanofi-Aventis to Create China Vitamin JV with Minsheng
PPD to Acquire China CRO Excel PharmaStudies
Chi-Med Ups Ownership of Hutchison Healthcare JV to 100%
Simcere Gains Majority Control of Vaccine Subsidiary
China Medicine Acquires Guangzhou LifeTech for $8.3 Million
Tianyin Pharma Creates New Antibiotic JV
NeoStem Closes China Biopharma Acquisition
Microbix to JV with Hunan Biopharma on $200 Million Flu Facility
Beike Biotechnology Invests in Biomaster, a Japanese Stem Cell Company
Biostar Raises $3.6 Million
Simcere Buys Manufacturing License for Statin
D-Pharm Outlicenses Stroke Drug to Wanbang Biopharma
China Establishes $1.3 Billion Emerging Industries VC Program
China Medicine Corp. Signs Term Sheet to Raise $59.5 Million
Advanced BioMedical Finds Partner for New Use of Medical Device
PPD Buys BioDuro, Its Second Major China CRO Acquisition This Month
Jennerex Out-Licenses China Rights for Cancer Drug to Lee’s Pharma
China Cord Blood Completes Secondary Offering on NYSE
China Nuokang Bio-Pharma Plans a Nasdaq IPO
Sinovac Adds Vaccine Capacity by Forming JV
Jiuding Capital Launches PE Fund for China Pharma
PPD Paid $77 Million to Acquire BioDuro
FORMA Therapeutics Closes $25.5 Million Series B
Concord Medical to IPO Next Week on NYSE
Milestone Scientific Forms China JV for Injection Devices
Institut Mérieux Plans China R&D Center
Sinopharm in Hunt for $3 Billion German Generic Drug Company
Disappointing Pricing for China Nuokang’s Nasdaq IPO
Sinocom Pharma Raises $15 Million
Biostar Announces $1 Million Acquisition
Guangzhou Improve Medical Instruments to IPO on ChiNext
Pfizer Extends Relationship with Peking University
Hard to Treat Diseases Sells Division to TCM Company
Fosun to Raise Capital for Expansion
Nextchem Pharma Reopens after Capital Infusion
Ranbaxy Sells China Manufacturing JV
GL Biochem Reaches Final Terms for Reverse Merger
$1.5 Billion Fund to Aid VC/PE Investment in Beijing’s Zhongguancun Park
China Medicine Raises $69.6 Million in PE from JPMorgan Chase
bioMerieux Buys Meikang, a China Rapid Test Manufacturer
Burdica Signs Up Sinopharm to Register, Distribute Products
Morningside Sets Up China Cancer JV with Can-Fite
New Summit Bio to be China Partner for Pacgen’s Thrush Treatment
Suzhou Nanomed Secures VC Funding from Softbank
Sanofi-Aventis Forms Another China JV with Minsheng
China Medicine Corp. Closes JPMorgan Funding
GCA Therapeutics to Commercialize Achillion’s HBV Treatment in China
Zhejiang Hisun Pharma Invests in US-based Sagent Pharma
Tongjitang Pays $18 Million to Acquire Guiyang Liquor
BioMarin Buys LEAD Therapeutics of California and Shanghai
3SBio Gains China Rights to Another Drug for Dialysis Patients
Private Equity Investors Seek Emerging Markets and China
3SBio and Ascentage Form Alliance to Develop Cancer Drugs
NeoStem Raises Cash to Build New Facilities
Sinovac Acquires New Manufacturing Facility
Fosun Increases In-Vitro Presence with Biosino Investment
Merck, Lilly and Pfizer to Construct Asian Cancer Database
Shenghong Buys New Drug Projects from Tibet Rhodiola
China Aoxing In-Licenses China Rights for Narcotic Drug Combo
Teva to Market Parkinson’s Drug in China for Lundbeck
aTyr/Pangu Announces Second Matching Grant in Hong Kong
WuXi PharmaTech Forms Pre-Clinical Collaboration with Janssen
Kalen to Offer Lipoprotein Research Products in China
Mindray Raises $152.8 Million in Secondary Offering
Hutchison MediPharma May IPO within Two Years
AutekBio to Build Largest Biologic CMO in Asia
EA Inc. Raises $6.6 Million from OrbiMed
TCT Medical Books $10 Million Investment from Fidelity
Chongqing Porton Secures $10 Million for Production Facility
Interfax-BW Releases
Login
Industry Insights
China Innovation: Biotech and Drugs #2
Biosimilars and China: Problems and Potential
Food and Drug Safety: Who is Really Responsible?
China Life Science Companies Make Mark at VC Conference
China's Five Year Plan for Biotech
Does China Have a Short-Sightedness Problem?
Asia Pacific Will Supplant US-Europe as Pharma Center
Taiwan v. China: The MediVas Case Study
Rumor Confirmed: SFDA to Speed Approvals
China Edges Ahead of India in Clinical Trials
China Biomedical Investing Gaining Momentum – Interview with Greg Scott
Zero2IPO Reports Jump in China’s Q3 VC/PE Investment and Exits
ChinaBio® Investor Forum 2007: China Life Science Investment Growing
Nature Biotechnology’s Overview of China Biotech
VCs Like China and Biotech for 2008
China CROs: The Agenda is Growth
KPMG: More JVs in 2008, Less M&A
ChinaBio® Today Editor Scott on China Life Sciences and IP
China’s Hepatitis B Market to Double by 2012
Charles River Says CRO Business Slowing
China Launches “Mega Program” to Fund Drug Development
Cancer Drug Market in China Was $3.6 Billion in 2007
The State of China Life Science in 2009 – An Introduction
The State of China Biotech – 2009 – Technology Development
The State of China Biotech – VC Investment
The State of China Life Science – IPOs and M&A
China Commits $9 Billion to Biotech and Other New Technology
US Real Estate Problems Present Opportunities for China Life Science Companies
Experts Discuss Potential of Partnering in China at the ChinaBio® Partnering Forum
A Big Pharma Perspective on Leveraging China’s Resources
The Impact of the Financial Crisis on Partnering in China
Successful Partnerships in China – Case Studies
How to Partner with China Life Science Companies
The Current State of China Life Science: China Ascendant
Are China CMOs the Next Big Thing?
China Pharmaceutical Market Growing at 22% Clip
IMS Health: China Leads Emerging Pharma Markets
Featured Companies
Shanghai Century Reports Financials for Acquisition Target
Featured Company: Post-IPO Numbers on Simcere
Featured Company: Benda Offers Gene Therapy
Featured Company: Sinovac Biotech Is a Bird Flu Play
Featured Company: American Oriental Stirs Up Controversy
Featured Company: Beijing Med-Pharm
Bridge Pharma Evolving Quickly
Featured Company: Beijing Med-Pharm Raises $31 Million
Shengtai Pharmaceutical: Strong Numbers; Weak History
Renhuang Seeks Respect
AMDL Launches Anti-Aging Product in China
Dragon’s New Production Process to Cut Costs
Sinobiomed Scores $1.2 Million Grant for Malaria Vaccine
Novartis Reports Higher China Revenues
Featured Company: CapitalBio Makes Biochips and VC Investments
Adaltis Focuses Diagnostic Business in China
Lotus Pharma Not Sleepy
Featured Company: GenePharma Atop Hot siRNA Tool Market
Financial Engineering at American Oriental
Featured Company: Is 3SBio Too Conservative?
Shenogen Pharma Blends East and West
Beike Uses Research Forum to Showcase its Stem Cell Therapies
LEAD Therapeutics: A New US-China Drug Discovery Model
PharmaLegacy, a Pharmacology CRO, Opens Its Doors
China Sky One Medical: A Company on the Move
ProteLight and BioAMPs Take on Antibiotic-Resistant Bacteria
Featured Company: HD Biosciences Receives Pfizer’s Top Partner Award
aTyr Using Hong Kong to Leverage Development of New Class of Biologics
Sinoasis Develops Proprietary Technology for Therapeutic Antibodies
GeneHarbor Technologies: Novel Enzymes for New Applications
Interview: China Looms Large for Bayer Growth Strategy
JOINN Takes Big Leap into China’s CRO Future
WuXi PharmaTech COO Highlights Growth
News & Analysis
Albumin Shortage in China
Lilly Growing in China
Genentech and Taiwan Company Partner on AIDS Drug
AstraZeneca Partners for Clinical Unit in China
DSM Opens Shanghai R&D Center
Siemens Medical Park Opens in Shanghai
China in Future Plans for Multinational Life Science Companies
Chongqing Kangwei Expects Approval for H. Pylori Vaccine
PATH starts Rotovirus Partnership with Wuhan Institute
Sanofi-Aventis Will Study Cancer Stem Cells in China
The Week In China: Simcere Pharma Files for American IPO
The Week In China: Cancer Therapeutics Sues Partner Peregrine
SinoBiomed Wins Approval Of Recombinant Growth Factor
ChinaBio Today Starts Publication
CRO Service Alliance Formed in Shanghai
China Sky One Medical Ups Q1 Revenue by 30%
Chengdu Hoist Wins Approval for Liver Cancer Drug
Hi-Tech Angel Fund in Tianjin
Mindray Gets OK for Two More Devices
Foreign Investment in China Grows in 2007
Skystar Signs New Orders
Chindex Signs Management Agreement for Chinese Facility
China Medical Climbs on Robust Earnings
China Sky One Awarded Municipal Grant
China-Biotics Reports Higher Revenues, Profits
Harbin Pharma Considers Foreign IPO
China Aims to Modernize Traditional Chinese Medicine
Skystar Cuts Production Costs
Healthcare Park to be Built in Suzhou
China Sets Lofty Goals for its Bioindustry
Syngenta To Collaborate with Chinese Institute
Microbix Biosystems Licenses Product to China
Hutchison MediPharma Reports Success for Ulcerative Colitis Disease Drug
GlaxoSmithKline Will Open Shanghai Research Center
Adaltis Signs Distribution Agreement for China
Cinpathogen Partners with Fudan University in Shanghai
Business Leaders Find China Best for Investment
Hansenpharm Co. Begins Selling Generic Zyprexa in China
Conglomerate Fosun Has Hong Kong IPO
Zhejiang Huahai Approved for Generic HIV Drug
China Medical Tech Starts US Cancer Trial
Chinese National Government Starts Small High Tech Fund
China Shenghuo Completes Phase II Trial of Ulcer Drug
Sinobiomed Approaching Launch of Ulceration Drug
Beijing Med-Pharm To Distribute Cancer Drug
AstraZeneca Cuts Worldwide Workforce While Investing in China
China Sky One Puts Eight New Tests in Clinical Trials
China Institutes Heavy Fines for Harmful Products
Sinovac and GSK to Co-Promote Flu Vaccine
China Closes 3 Plants That Produced Lethal Products
Bridge Pharma's China Lab Gets Accreditation
Top Chinese Drug Producers
OECD: China Needs More R&D Reforms
Summit Lifesciences Included on Hot Asia 100 List
Phillips to Build Molecular Medicine Lab with Shanghai Institute
Student Engineers Design Medical Diagnostic Device for China
AMDL Increases Pipeline
Sanofi-Aventis Continues Patent Fight with Jiangsu Hengrui
Russian CRO Synergy Seeks Partner in China
Benda Books Record Gendicine Orders
AstraZeneca and Political Correctness
PPD Names Vice President for Asia
WuXi Begins Building GLP Center in Suzhou
TCM Delisheng Shown Effective Against Cancer
China Biopharma Reports Progress on Topical Antiviral
AstraZeneca Sourcing Seroquel API in China
MDS Moves to Bigger Lab in Beijing
Roche Building Fully Functional R&D Center
Novartis to Build $700 Million Plant in Singapore
IBF 15th Annual Biotech Investing Conference
WuXi PharmaTech Triples Earnings in Q3
LEAD Therapeutics and ShangPharma in Strategic Relationship
Unit Sales Down, Revenues Up at China Biologic
China’s BioPharma Growth Detailed
Helicon Building Portfolio of Products for China
Genesis Signs Pact with Chinese Academy of Sciences
Organogenesis Partners with National Tissue Engineering Center
China Aoxing Given Preferred Status for Cancer Pain Drug
Sanofi-Aventis To Build Flu Plant in Shenzhen
China Biopharma Searches for Mission, Money
Skystar Opens Veterinary R&D Center in Shanghai
ChinaBio® Forum Gives “Most Promising” Award to Two China Biotechs
GSK Ups China R&D Investment
Sinovac On a Roll
Contaminated Merck Vaccine Recalled in China
Novelos Out-Licenses China Rights for Two Compounds
New US-China CRO Joint Venture Formed
Vital Therapies Scores Clinical Success in China
Asymchem Labs Ups its China Investment – Again
China’s Gene Therapy Cancer Drugs: Great Science, Slow Acceptance
Agenix Announces Initial China Sales of Hep B Drug YouHeDing
Benda Receives GMP For Expanded Plant
Calypte’s Receives OK for China HIV Diagnostic Test Facility
Access Outlicenses China Rights for Mucositis Product to RHEI
Benda Begins to Deal with Upcoming Financial Problem
China Biologic Awarded Innovation Grant
Bridge Labs Lands $18 Million in New Funding
Renhuang Announces “Major Breakthrough”
PPD Opens Central Lab Services Unit in Beijing
China VC Investment up 83% in 2007
WuXi PharmaTech Puts Squeeze on Suppliers
China Shenghuo to Bring TCM-based Cosmetics to US
Charles River: "China Work for China Ops of International Pharma"
Baxter’s Heparin Problems May Have China Connection
Tianyin Pharma Reports 70% Increase in First Half Revenues
NovaSecta Forms Alliance with Sundia MediTech and HD BioSciences
Omnicare Opens China Offices
3SBio Reports Higher Q4 But Misses Estimates
QIAGEN Opens Asia Customer Service Center
Two Japanese Drug Wholesalers Set Up China JVs
China Pharma Notes Boost from Generic Cold Drug
BMP Sunstone Says Propess® Recommended for Induction of Labor in China
Provectus Granted China Patent for Imaging Drug
Simcere Books Very Strong 2007
Heparin, Baxter, the FDA and China
American Oriental Revenues Up 46% in 2007
Tongjitang Reports Zero Net Operating Income for Q4
CRO Global Research Expands in China
WuXi PharmaTech Reports Higher Q4 and 2007 Financials
US Journal Says TCM Leukemia Drug is Effective
VisCorp Morphs into Tianyin Pharmaceutical
China a Priority for AstraZeneca
Chi-Med Ups Both Revenues and Losses
3SBio Addresses Falling Share Price with Buyback
Shanghai GenePharma Licenses Alnylam siRNA Patents
China Medicine Corp. Grew by 75% in 2007
Sinovac Says 2007 Revenues Up 118%
Boehringer Ingelheim China Profits from Sinopharm Deal
China Biopharma Stocks Suffer Tough First Quarter
China Sky One Reports Higher 2007 Revenues, Profits
Sanofi-Aventis Seeks China Partnerships, Not a Research Center
Wyeth Complains China IND Process Is Too Slow
China Shenghuo Reports Flat Revenues
Aida Pharma Affiliate Developing New Antibiotic
Becton, Dickinson Opens Diagnostic Products Facility in Suzhou
WuXi Endows Professorship at Tongji University
Aida Reveals Second Anti-Cancer Drug
Genzyme to Build $90 Million R&D Center in Beijing
Beijing Genomics Institute Expands Sequencing Capacity
China Pharma Holdings Issues Earnings Tease
CRO Service Alliance Expands Again, Adding Tigermed
Novo Nordisk Donates Compound Library to China Center
China Pharma Delivers on Improved Financials Promise
GlaxoSmithKline Reorganizes to Emphasize Emerging Markets
Simcere’s Q1: Revenue Increases 26%; Net Up 68%
American Oriental Reports Improved Q1
Mindray Tops Estimates in Q1
China Medicine Corp. Says Revenues, Profits Climb Again
Tianyin Pharma Wins Tenders for Ginkgo Mihuan
China Sky One Reports Record Quarter
China Earthquake Shutters Tongjitang Medicines Facility
3SBio’s Q1 Revenues Rise, Though Net Income Lags
Sinovac’s Q1 Doubles Its Year-Earlier Results
Oculus Announces China Marketing Plan for Microcyn
Calandro Pharma Granted China RNAi Patent
Two Announcements from Tongjitang Chinese Medicines
Suven Granted Two Patents for New Neuro Drug Candidates
China Yongxin Completes Reverse Merger
Lotus Reports Higher Q1 and New Asthma Drug
China Sky One Will Move Listing to American Exchange
American Oriental Prepays $16 Million for Acquisitions
Sinovac Receives Vaccine Order for China Earthquake Victims
WuXi Reports Improved Quarter, Again
Did AppTec Acquisition Hurt WuXi PharmaTech’s Q1?
China Sky One Soars after Releasing Strong 2008 Results
Tongjitang Chinese Medicine’s Q1 Report Disappoints
ShanghaiBio to Offer siRNA Screening Services
Asymchem Keeps Building as API Sourcing Reacts to Heparin Scandal
China Sky One Ups Forecast; Hits New High
Sinovac Receives 80,000 Dose Vaccine Order for Earthquake Victims
China Medical Reports Improved 2007
Vibrant Burrill India-China Meeting in San Diego
Will Bayer AG Be #1 in 2008 China Prescription Drug Sales?
BIO2008 Panel: Opportunities/Challenges in Asian VC Investment
Doing Business in Asia – Is China Becoming Too Expensive?
Renhuang Granted “Key Laboratory” Designation
ChinaBio® Makes "Most Promising Company" Awards
Bayer Seeks Over 20% Annual China Revenue Growth
CRO Sundia MediTech Makes Venture 50 List Again
GSK to Double China R&D Staff
MedMira Granted China Patent for Diagnostic Device
Bridge Labs To Build Second China Facility
Huifeng Reports Progress on Diosmin Contract
SinoBiomed Wins Patent Approval for Recombinant Viper Venom
Eisai China to Repack and Sell STADA Diabetes Drug
China Medical Reports Higher First Quarter
Simcere’s Q2 Revenue Below Expectations
China Pharma Holdings’ Growth Moderates in Q2
Pfizer Moving Bioinnovation Center to San Francisco
Lonza to Offer Life Science Engineering Services in China
BMP Sunstone Reports Excellent Q2
China Sky One’s Q2 Beats Estimates
Sinovac Q2 Revenues Climb 73%
3SBio Reports Higher Q2 Revenues, But Earnings Slip
WuXi Reports Solid Q2 Financials
China Sky One to Produce Nasal Spray for Rheumatic Disease
Tongjitang Chinese Medicines Revenues Lower in Q2
Benda Not Able to Capitalize on Gene Therapy Cancer Drug
Lotus Pharma Reports Higher Revenues, Lower Net
MicuRx Pharma Picks Next-Gen MRSA Antibiotic Candidate
China Shenghuo to Restate Financial Results
Sinobiomed: Negative Financials; Vibrant Development Program
Smith & Nephew Expanding China Operations
China Sky One Will Migrate to NASDAQ Global Market
Genesis Pharma Completes 40-to-1 Reverse Split
Mindray Rides Datascope Acquisition for Strong Q2
BioBay Investor Forum 2008: By 2015, Yangtze River Delta Will Boast World’s Largest CRO Cluster
BioBay Investor Forum 2008: China Pharma to Boost Value with Global Patents
Tongjitang Announces $20 Million Stock Buyback
Tianyin Pharma Reports Higher Fiscal 2008 Revenues and Profits
BusinessWeek Highlights Sea Turtle Phenomenon
Sinovac Launches 2008-2009 Version of Flu Vaccine
Oculus Launches Dermacyn™ in China
Genesis Announces $12 Million in New Orders
China Biopharma Executes 1-for-100 Reverse Split
Xel Pharma Announces TCM Patch for Alzheimer’s
China Infant Formula Scandal Tied to Melamine
China Pharma Ups Q3 Revenue Guidance
China Sky One Reports Progress on CE Mark
PricewaterhouseCoopers: Where to Outsource in Asia?
China Pharma says Collection of Accounts Receivable is Improving
IPEC China Gives Voice to Excipient Industry
Sinovac to Develop Hand, Foot and Mouth Disease Vaccine
China’s Baby Formula Coverup Started 10 Months Ago
Phynova Plans Greater China Focus
Tianyin to Move to AMEX Exchange
China Sky One Raises 2008 Guidance
Tianyin Pharma’s 2008 Results Reach Expectations
Shengtai Pharma Reports Improved Results in 2008
Genesis Pharma Books 31% Higher Revenues in 2008
The China CRO, CMO and Clinical Trial Markets
Shengtai Receives GMP Certification for Glucose Facility
TCM Remains Vital Part of China Healthcare
China Medicine Guides Lower, Blaming Economic Crisis
Beike Biotech Signs Eight Cooperation Agreements
Injectable TCM Blamed for Three Deaths
WuXi Misses Q3 Forecast; Guides Lower for Year
China Sky One Starts Production at New Subsidiary
Crown Bio to Build Second China CRO Facility
Charles River and Shanghai BioExplorer Open CRO Facility
China Aoxing Issues 2008 Financial Report
WuXi Expands J&J Collaboration
Outbreak of CRO and Big Pharma Activity in China
Tianyin Boosts Stock Price with Buyback
Shengtai Pharma to Seek Growth in International Sales
Sundia Named to Deloitte Fast 50 China
Covance Not Hurrying to Build More China Facilities
Tongjitang Can Start $20 Million Share Buyback
3SBio’s Q3 Hurt by Lehman Bankruptcy
Sinovac Included in Deloitte’s Technology Fast 50 China
WuXi Receives Global Supplier Award from Lilly
Roche Expanding in Shanghai; Opens Partnership Office
BioCurex to Offer Cancer Tests in Shanghai
Simcere Reports Improved Q3; Starts Buyback
Novo Nordisk to Build $400 Million China Manufacturing Plant
China Pharma Reports Higher Q3; Accounts Receivable also Up
American Oriental Books Another Good Quarter
Wall Street Unhappy with Mindray Medical’s Q3
Tianyin Pharma Reports Higher Revenues and Costs
Six Cases of Avian Flu in China This Month; Five Deaths
BMP Sunstone Revenues on the Rise in Q3
China Biologic’s Revenues and Profits Soar in Q3
China Medicine Reports Lower Q3
Shengtai Pharma Begins FY2009 with Small Drop
Genesis Pharma Reports Higher Q1
China Medical Releases Selected Q2 Data
International Big Pharma Continues China Investment
Lotus Increases Profit in Q3 while Revenues Drop
Sinovac’s Revenue and Profit Slide Lower in Q3
ChinaBio® Schedules First Partnering Forum for June 2009 in Shanghai
China Medical Develops Predictor for Biologic Cancer Drug Success
Syneron Forms Medical Device JV in China
China Shenghuo Completes Restatement; Issues Q3 Report
China Meditech Pays $3.3 Million for R&D Facility
Tongjitang Reports a Down Q3
China to Spend almost 5 Billion RMB on Rural Healthcare
Sinovac’s Hepatitis A Vaccine Suspended Following Child's Death
WuXi Will End Biologics Manufacturing in US
Sinovac Reports Adverse Effects from Vaccine Limited to One Case
AnaSpec Signs Second China Distribution Deal
China Shenghuo Resumes Trading; Price Drops 50%
BioDuro Labs Accredited by AAALAC
Cook Medical to Open Asia Regional Center in Shanghai
Fountain Medical and ProteLight Receive ChinaBio®'s "Most Promising" Award
Officials Suspect Mutation in Bird Flu Caused Hong Kong Outbreak
China Biologic Announces $1.6 Million International Sale
Baiqiang Pharma Builds Cancer Drug Capacity
China Sky One Awarded Science Prize for BPH Drug
Sinovac’s Healive® Vaccine Not Responsible for Infant’s Death
Niusule Lists on Bulletin Board
ChinaBio® Stock Index Drops 57% in 2008
BMP Sunstone Company Granted High Tech Status
e-Therapeutics to Offer Computational Biotech Services from Nanjing Office
Simcere Warns that 2008 Net Income Will Miss Forecast By 10%
Mindray Medical Reports Much Higher 2008
China Pharma Announces SFDA Approval of Hepatitis B Drug
China-Biotics Says New Plant Delayed
Mindray Medical Reviews New Products for 2008/2009
Abbott Opens Singapore R&D Center
BMP Sunstone Guides 36% Higher for 2009
China Pharma Holdings Inc. Sees Improvement
China Bio-Immunity Recalls Rabies Vaccines
China YTC Announces Big Increase in Latest Quarter
Tianyin Pharma to Start $3 Million Buyback
Sinobiopharma Prospers on Muscle Relaxant Drug
Lotus Will Build Factory, Pharma Park in Inner Mongolia
Fosun Again Increases Tongjitang Stake
China Bio-Immunity Recovers Most of Recalled Rabies Vaccine
CRO Sundia Identifies Four Pre-Clinical Candidates for Xcovery
Zhangjiang Park and CRO Sundia MediTech Form Incubator
China Uses Sinovac Product for Bird Flu Vaccine Stockpile
Bayer Schering Will Build $129 Million Beijing R&D Center
Shengtai Pharma’s Second Quarter Disappoints
China-Biotics Reports Improved Q3
Genesis Reports Higher Revenues, Flat Net
Sinobiomed, Needing a Turnaround, Replaces Entire Management Team
Beijing Announces $74 million in Biotech Grants for 2009-10
A Drug Development Update from Obio Pharma
Jingang Andi Officials Detained for Unapproved Additive to Rabies Vaccine
Sinovac’s New Filling Facility Given GMP Cert
China Medical Announces Higher Q3
Mindray’s Higher 2008 Results Fail to Impress Investors
Novartis Announces 30% Increase in 2008 China Revenues
American Oriental Reports Solid Numbers; Investors Remain Wary
Biostar to Build Own Raw Material Processing Facility
How Does the Merck/Schering-Plough Merger Affect China?
Simcere’s Q4 Revenues Climb, but Earnings Are Down
3SBio Reports Higher Sales, Flat Earnings
China’s First Partnering Conference Set for June
China Pharma Holdings Reports Improved 2008
BMP Sunstone Rides Acquisition to Record 2008 Revenues
Bayer and Tsinghua University to Form Joint Institute
Tongjitang Chinese Medicines Releases Dismal Q4 Report
Pfizer Works with NGO to Provide Healthcare for China’s Working Poor
Two Biotech Companies Receive “Most Promising Company” Awards in Hong Kong
SGS Life Science Services Offers API Testing
WuXi PharmaTech’s 2008 Meets Expectations, Though AppTec Disappoints
China Medicine Corp. Grew Again in 2008
Agilent, Shanghai Institutes and Tongi University Publish Stem Cell Discovery
Tiens Biotech Says 2008 Revenues Climbed 41%
Kun Run Reports Strong 2008 Results
Zhangjiang Hi-tech Park Sets Up $147 Million Life Science Fund
China Biologic Keeps Growing
IMCAS and TB Alliance will Search TCM for TB Drug
Biostar Doubles Revenues in 2008
China Sky One Says Financial Reports Await Only a Technical Ruling
Covance’s Shanghai Lab Receives CAP Accreditation
China to Build Major Stem Cell Center in Taizhou
China's Big Hospital/Clinic Construction Plans
Sinobiopharma Seeks Patent for new ACE Inhibitor Formulation
Sinovac Reports 39% Higher 2008 Revenues
China Scientists Challenge Long-Held Fertility Principle
Lilly Emphasizes China in Strategic Plan
New GM for Bridge Labs' Beijing Facility
China Medicine Corp. to Distribute Anti-Adhesive
Lotus Books Solid 2008; Still Needs Cash
Sanofi-Aventis to Build $90 Million China Manufacturing Facility
Genesis to Launch Three Newly Acquired Products
Tianyin Reports Successful Tender Process for Major Drug
Lotus Adds Color to 2008 Financial Report
China Biologic Products Lands $5.3 Million Order from India
Novozymes Breaks Ground on New China Manufacturing Facility
Sinovac Receives $12 Million Vaccine Order
Alnylam Granted Additional China Patent for siRNA
Sinovac Takes Steps toward Producing Swine Flu Vaccine
Simcere to Make and Market Flu Drug Zanamivir in China
Cuba Begins China Registration of Diabetic Ulcer Drug
Tianyin Pharma Expects July Launch for New Manufacturing Facility
American Oriental Reports Higher Revenue, Lower Profit in Q1
Jiangbo Completes Name/Ticker Change from Genesis
Mindray’s Q1 Underwhelms Investors
China Medicine Corp. Drops on Improved Q1
China Sky One Doubles Year-Earlier Revenues in Q1
WuXi PharmaTech Surprises with a 5% Q1 Revenue Increase
Sinovac Announces Much Lower First Quarter
China Aoxing’s Revenues Climb; Net Income Still Negative
China Shenghuo Announces Large Loss on Higher Revenues
BMP Sunstone Reports Large Q1 Revenue Gain and a Non-GAAP Profit
Simcere Buys 35% Stake of Antibody Company, Announces Q1 Results
Baxter Commits 1 Billion RMB to Increase Manufacturing in China
ChemWerth Teams Up with Tianjin Tianyao for Corticosteroids
Biostar’s Q1 Revenues Rise 9%
Roche Opens China Application Support Center
China Set for Quick Development of A/H1N1 Flu Vaccine
Porvair Signs China Microplate Distribution Agreement
Sinopharm Medicine Rumored to be Considering October IPO
Luminex Opens Asia-Pacific Center in Shanghai
Tongjitang Chinese Medicines Disappoints Again
Chip-Man Markets Cell-IQ through ChiFi Biomedical
Sinovac Starts Influenza A (H1N1) Vaccine Production
Shenyang Officially Opens Pharmaceutical Park
Sundia MediTech Says Animal Lab Passes Audit
Lilly Offers Free Testing for Novel Compounds
Vital Images to Offer Scanning Software in China through Chindex
Tianyin Issues Early Financial Report of Positive 2009
China Medical Tech Says 2008 Revenues Climbed 51%
Guilin Sanjin Pharma Will Be First China IPO of 2009
Pfizer Wants to Do Deals in Emerging Markets
Sinovac Lands H1N1 Flu Vaccine Order
China’s First Partnering Conference Draws Large Global Audience
WuXi Named One of China’s Top 10 Outsourcing Companies
Micro Imaging Hires OPH for China Expansion
Rural Heathcare in China to Receive 100 Billion RMB for Facilities
Sichuan Hospital and Harvard Collaborate on Transplant Studies
China Wants to Double TCM Production
China Ministry Puts 10 Billion RMB into Health Insurance
Neuralstem Sponsors 2nd Stem Cell Research Project in Taiwan
China Sky One Receives GMP Renewal
China-Biotics Reports Gains in FY2009
China Medicine Cites Positive Data on Animal Feed Additive
Lijun International Pharma Reports Strong First-Half
Novartis to Offer Management BiMBA in China
Sundia Named to Top 100 Fast-Growth Outsourcing List
Mindray Medical Releases Product Update
AlphaRx Seeks Local Partners for China R&D and Pilot Plant Facilities
American Oriental on China’s Top 20 Pharmas List
AlphaRx Signs Cooperation Agreement with Venturepharm
Lotus Receives Patent for Diabetes Drug
Pfizer and Fudan University Offer Work-Study Graduate Degree
China Medical Lowers Guidance; Blames False Allegations
Commonwealth, Seeking to Acquire Shanghai’s GL Biochem, Faces Delisting
AlphaRx to Conduct R&D inside Venturepharm’s Taizhou Facility
Shanghai Biochip Develops DNA Test to Determine Children’s Abilities
Lonza Completes Phase 2 of Nansha Plant Expansion
China Sky One May Raise New Capital for Acquisitions
American Oriental’s Q2 is Mixed; New Product Announced
Pasteur Institutes in Shanghai and Paris Discover New Rhinovirus Genomes
Mindray Medical Rises After Reporting 10% Increase in Q2 Revenue
3SBio Announces Solid Q2; Looks Toward Biosimilar Market
WuXi PharmaTech Beats Q2 Estimates
Welch Allyn Offers General Practitioner Training in Guangzhou
Fosun Ups Tongjitang Stake to 24%
US Pharmacopeia Certifies First TCM
China Sky One’s Q2 Revenue is Up 36%
Sinovac Prospers in Q2 on Large Government Order
Simcere Teams Up with Sun Yat-Sen University Cancer Center
American Oriental Has Approval for 61 Essential Drug List Products
China to Sell 10 Million Doses of Swine Flu Vaccine to Mexico
Sinovac To Supply Beijing with Seasonal Flu Vaccine
China Sky One Says SAIC Filings Underreported Revenue
2009 Revenues for Drug Products in China Likely to Top $110 Billion
Sundia given Growth Potential Award by Zhangjiang Park
China Medical Technologies Still Stumbling
China Orders Flu Vaccine from Sinovac, Hualan; Approves Relenza
20 Guangzhou CROs Form Alliance
China Sky One Selling TCM Pain Relief Patch in Canada
Leveraging China to Build a Global Biotech
Benitec and Biomics Join to Develop RNAi Drug for Hepatitis B
American Oriental Launches Laryngitis Capsules
Four of Tianyin Pharma’s Generic Drugs on Essential Drug List
LEAD Therapeutics Announces New Antibiotic
SFDA Approval Granted to SIBS Swine Flu Vaccine
Tianyin Pharma’s New Solid Dose Facility Granted GMP
China Medical Announces $30 Million Share Buyback
Genzyme Starts Work on $100 Million Beijing R&D Center
AMDL Hopes to Spin-Off Jade Subsidiary to GEM Exchange
BioTime Announces China Stem Cell Subsidiary
China Biologic to Collaborate with Institute of Blood Transfusion
Tianyin Pharma Hits 2009 Targets
Mimotopes China & VPSmart-DDS Biodelivery Centers Opens in WuXi
Health Robotics Signs IV Robot Deal with SINOPHARM
Shenzhen Commits 3.5 Billion RMB for Biotech Development
Eisai to Market Kyorin's Overactive Bladder Drug in China
China Requires One Divestiture for Pfizer-Wyeth Merger
Sinovac Receives Big H1N1 Vaccine Order
Lilly China to Double Workforce
Ingen Granted China Patent for Medical Device
Merial Starts $70 Million China Animal Health Facility Expansion
Tongjitang Completes $20 Million Stock Buyback
Biostar Granted Patent for Second TCM Hepatitis B Product
China Researchers Use Bioluminescence to Map Eye Cancer
Servier Collaborates with SIMM on Cancer Drug Discovery
California and China Agree to Collaborate on Stem Cells
China Biologic Products Receives Forbes Magazine Honor
BioTime Investigating Stem Cells to Treat Cancer
Bonovo to Distribute Medical Devices for elliquence in China
Boehringer Ingelheim Adds $149 Million to its Investment in China
Sinovac Snags Another Large Order for Flu Vaccine
Medicilon/MPI Receives AAALAC Accreditation
Sinovac to Move Listing to NASDAQ Global Exchange
Novartis to Invest $1 Billion in China
Roche Opens $500 Million Biologics Facility in Singapore
Novartis Adds $375 Million in China Investments
ScinoPharm Constructing Facility in Changshu
Pfizer’s Shanghai Operation Saved from Company's R&D Cutback
Lijun Says Enerxin Capsules Effective in Treating H1N1 Flu
BMP Sunstone to Distribute Pfizer’s Endometriosis Treatment in China
China’s Research Output Could Surpass the US in Ten Years
WuXi PharmaTech Signs LOI to Establish New Company
Early Earnings Season: Medical Devices Flat; Biopharmas Higher
Sinovac’s Q3 Soars; Company Announces New Vaccine Contract
WuXi PharmaTech Reports Higher Q3
American Oriental’s Financials Disappoint Again
Tongjitang Reports Another Down Quarter
Students from China Coming to US in Record Numbers
Goldman Sachs Puts Pfizer’s 2012 China Sales at $3 Billion
GSK to Manufacture Flu Treatment Relenza in China
Merck Serono to Spend $225 Million on Beijing R&D Center
GSK Will Seek to Commercialize Viread in China for Hepatitis B
Pfizer Adds R&D Center in China
AstraZeneca to Offshore All API Production
Sinovac Receives a 1 Million Dose Order for H1N1 Vaccine
China Sky One to Sell Diagnostic Kits in Southeast Asia through Agent
Simcere Shuts Down Production in New Vaccine Subsidiary
AlphaRx Incentivized to Locate in Zhangjiang Park
Tianyin Pharma Calls for 75% Improvement in 2011 Results
Medicilon/MPI Accredited to Provide US GLP Services in China
Hubei Guangji Pharma Starts Building Major Biopharma Park
Lilly Aiming at China’s Growing Pharmaceutical Market
aTyr Publishes Groundbreaking Research
Pfizer will Co-promote Takeda Diabetes Drug
Novartis Opens Suzhou Plant and Technical R&D Center
Cellonis Biotech Eliminates a Glioma with Stem-Cell-Based Therapy
NiTi Reports First China Use of Surgical Device
Sinovac Named One of China's Top 10 Most Competitive Companies
Alvogen Opens Office in China
WuXi PharmaTech and Sundia MediTech Named Again to Fast 500 Asia Pacific
Syngenta Biotechnology Breaks Ground on Beijing R&D Center
Hutchison Chi-Med to Outsource Development of a TCM
Biostar Pharma to Sell Hepatitis B Treatment in Beijing and Shanghai
China Sky One Qualifies for NASDAQ Global Select Market
China Reports 648 Deaths from Swine Flu in 2009
Mindray Medical Reviews New Products and Reveals Future Plans
WuXi and QIAGEN Form Biomarker Partnership
China Sky One Wins National Innovation Award for Diagnostic Kit
Invida to Market Three Dermatology Products in China
Sinovac’s Sales of H1N1 Vaccine Now Top 20 Million Doses
ChinaBio® Accelerator to Help Life Science Companies Establish China Operations
Suven Granted China Patents for Two New Chemical Entities
Jiangbo Pharma’s Bone Drug Included in Basic Medical Directory
Changzhou Begins Construction on Biopharma Incubator
Sinobiopharma Announces Improved Q2
Pfizer Sees Future Deals as China Biopharma Consolidates
China Sky One Shifts Emphasis to Generic Western Products
Shandong Luoxin Pharma Lists ADSs on OTCQX Exchange
Hong Kong Led Global Exchanges in 2009 IPOs
Covance Building Pre-Clinical Facility Near Shanghai
Sinobiopharma’s Flagship Product OK’d for Insurance Coverage
Response Biomedical Signs Second China Partner
Huifeng Bio-Pharma Expects 50% Revenue Increase in 2010
Gorbec to Open GMP Analytical Lab in China
Tianyin Pharma Hits Targets for Fiscal Q2
Celsis In Vitro Technologies Finds China Distributor
Charles River Labs Disappointed by Weak Demand for its China Lab
Bayer Seeks Better than 20% Growth in China
CRH Medical Finds China Distribution Partner for Medical Device
Narhex Declares Bankruptcy; Involved in Xi’an JV
The Hamner Institutes Adds Europe to its US-China Partnerships
WuXi PharmaTech Granted AAALAC Accreditation for Suzhou Animal Lab
Dishman Expects Shanghai Facility to be Operating in Q3
Biostar Expects 2010 Revenues to Climb Higher
Mindray Medical Reports Stellar 2009 Results
Asymchem Plans Another Facility at TEDA
Generex Granted China Patent for Cancer Vaccine
Sanofi-Aventis Looking for More China Partnerships
SEED Competition for China Life Science Announces Finalists
WuXi PharmaTech Reports Solid Performance in 2009
Lotus Pharma Breaks Ground on New Building
Sundia MediTech Founder Receives “Entrepreneur of the Year” Award
FDA Issues Warning to China API Maker
Lee’s Pharma to Distribute Recordati Hypertension Drug
MicuRx Files IND in China for New Antibiotic
Vycor Medical to Register Brain Surgery Device in China
China Sky One Predicts Improved 2010; Changes Focus
Sinovac Finds India Partner for H1N1 Vaccine
Zhangjiang Park to Cooperate with Swedish Counterpart
Novartis’ China Revenues Climb 36% in 2009
Subscription Plans
Login
Username / Email:
Password:
Remember Me
Subscribe
Forgot password?
>> Login help...
ChinaBio® Events
ChinaBio® Executive Workshop
April 14, 2010
Guangzhou, China
SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
ChinaBio® Partnering Forum 2010
Suzhou, China
June 23-24, 2010
>>
More details...
Partner Events
China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010
>>
More details...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
About Us
Subscription Plans
Site Features
News
Events
Our Partners
Contact Us
